<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Virulence</journal-id><journal-id journal-id-type="iso-abbrev">Virulence</journal-id><journal-title-group><journal-title>Virulence</journal-title></journal-title-group><issn pub-type="ppub">2150-5594</issn><issn pub-type="epub">2150-5608</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7939560</article-id><article-id pub-id-type="pmid">33660565</article-id><article-id pub-id-type="doi">10.1080/21505594.2021.1889812</article-id><article-id pub-id-type="publisher-id">1889812</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Pathogenicity and virulence of <italic>Streptococcus pneumoniae</italic>: Cutting to the chase on proteases</article-title><alt-title alt-title-type="left-running-head">M. E. MARQUART</alt-title><alt-title alt-title-type="right-running-head">VIRULENCE</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Marquart</surname><given-names>Mary E.</given-names></name><xref ref-type="aff" rid="aff0001"/><xref ref-type="corresp" rid="an0001"/></contrib><aff id="aff0001">Department of Microbiology and Immunology, <institution-wrap><institution>University of Mississippi Medical Center</institution></institution-wrap>, <city>Jackson</city>, <state>Mississippi</state>
<country>USA</country></aff></contrib-group><author-notes><corresp id="an0001">CONTACT Mary E. Marquart <email xlink:href="mailto:mmarquart@umc.edu">mmarquart@umc.edu</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>4</day><month>3</month><year>2021</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>4</day><month>3</month><year>2021</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>12</volume><issue>1</issue><fpage seq="54">766</fpage><lpage>787</lpage><permissions><copyright-statement>&#x000a9; 2021 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2021-03-02">http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="KVIR_12_1889812.pdf"/><abstract><title>ABSTRACT</title><p>Bacterial proteases and peptidases are integral to cell physiology and stability, and their necessity in <italic>Streptococcus pneumoniae</italic> is no exception. Protein cleavage and processing mechanisms within the bacterial cell serve to ensure that the cell lives and functions in its commensal habitat and can respond to new environments presenting stressful conditions. For <italic>S. pneumoniae</italic>, the human nasopharynx is its natural habitat. In the context of virulence, movement of <italic>S. pneumoniae</italic> to the lungs, blood, or other sites can instigate responses by the bacteria that result in their proteases serving dual roles of self-protein processors and virulence factors of host protein targets.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>Peptidase</kwd><kwd>protease</kwd><kwd>proteinase</kwd><kwd><italic>Streptococcus pneumoniae</italic></kwd><kwd>virulence</kwd></kwd-group><counts><fig-count count="2"/><table-count count="1"/><ref-count count="124"/><page-count count="22"/></counts></article-meta></front><body><sec id="s0001" disp-level="1"><title>Pathogenesis: Colonization, establishment of disease, and immune subversion</title><p><italic>Streptococcus pneumoniae</italic> (pneumococcus) is carried in the human nasopharynx of a varied percentage of individuals (moreso in children) and can maintain residence there, or spread to other body sites and cause opportunistic infections. The commonly known diseases caused by <italic>S. pneumoniae</italic> are pneumonia, otitis media, meningitis, and septicemia, although these diseases are not a comprehensive list. Transmission of pneumococci between individuals occurs through close contact and aerosols, and colonization is considered a prerequisite for disease although many colonized individuals do not experience symptoms. Therefore, the ability of <italic>S. pneumoniae</italic> to adhere to nasopharyngeal mucosal epithelial cells is an important step in the process leading to pathogenesis. Pneumococcal factors shown to play roles in host cell attachment are surface proteins such as pneumococcal surface adhesin A (PsaA) and choline-binding protein A/pneumococcal surface protein C/<italic>S. pneumoniae</italic> secretory IgA binding protein (CbpA/PspC/SpsA). PsaA binds to host E-cadherin [<xref rid="cit0001" ref-type="bibr">1</xref>] and CbpA/PspC/SpsA binds to sialic acid, lacto-N-neotetraose, the polymeric immunoglobulin (Ig) receptor, and vitronectin [<xref rid="cit0002" ref-type="bibr">2&#x02013;4</xref>].</p><p>The next general step in pneumococcal pathogenesis is establishment of the bacteria in the lungs, blood, middle ear, central nervous system, or other site. The mode of this establishment depends on host susceptibility, regulation of bacterial gene expression, and the opportunity for interactions between <italic>S. pneumoniae</italic> and host components. In the case of pneumococcal pneumonia, pneumococcal neuraminidase (NanA) is essential for cleavage of sialic acid from host cell glycoprotein receptors, thus promoting attachment of <italic>S. pneumoniae</italic> to airway epithelial cells [<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0006" ref-type="bibr">6</xref>]. Pneumococcal pneumonia is characterized by lung inflammation as a result of bacterial factors eliciting pro-inflammatory cytokine responses and immune cell recruitment. The cholesterol-dependent cytolysin, pneumolysin, contributes to these inflammatory effects in addition to its role of forming pores in eukaryotic cell membranes [<xref rid="cit0007" ref-type="bibr">7</xref>,<xref rid="cit0008" ref-type="bibr">8</xref>].</p><p>Regardless of whether <italic>S. pneumoniae</italic> remains confined to the lung or spreads to the blood to cause septicemia, the bacteria are confronted with various host defenses. Pneumococci utilize strategies to escape or modify the immune response to survive. For instance, when bound to the mannose-receptor C type 1 on dendritic cells or alveolar macrophages, pneumolysin promotes uptake of <italic>S. pneumoniae</italic> and subsequent escape from lysosomes [<xref rid="cit0009" ref-type="bibr">9</xref>]. In the blood, pneumococcal surface protein A (PspA) and the outer polysaccharide capsule contribute to bacterial survival. One of the contributions of PspA is to shortcircuit opsonization of pneumococci by inhibiting complement C3 deposition [<xref rid="cit0010" ref-type="bibr">10</xref>]. The capsule aids in protection from phagocytosis by masking pneumococcal surface antigens from C3 [<xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0012" ref-type="bibr">12</xref>], and reduces pneumococcal enmeshment in neutrophil extracellular traps [<xref rid="cit0013" ref-type="bibr">13</xref>].</p><p>Discovery of functions not previously ascribed to well-known pneumococcal virulence factors underscores the fact that, despite pneumococcal pathogenesis having been studied for over 100&#x000a0;years, new information regarding <italic>S. pneumoniae</italic> virulence factors and mechanisms as well as host responses continues to be uncovered. Shifting trends in epidemiology, longer life expectancies, human crowding, and strain selection caused by antibiotic use and pneumococcal vaccination contribute to new information. Additionally, advancements in molecular, biochemical, and bioinformatic methods have revolutionized the understanding of pneumococcal pathogenesis. One of the topical gaps in our knowledge that has the potential for providing key information regarding the virulence of <italic>S. pneumoniae</italic> is the protease.</p></sec><sec id="s0002" disp-level="1"><title>Proteases</title><p>Proteases are enzymes that cleave proteins and peptides, and are ubiquitous in the different kingdoms of life. Generally, these enzymes either hydrolyze peptide bonds within, or cut the bonds near the amino- or carboxyl-terminal ends, of proteins. Their functions are wide-ranging and include processing or degradation of improperly folded proteins and preparation of pre-proteins for secretion by signal cleavage. Bacterial proteases play key roles in cell homeostasis, protein transport, and cell wall structural integrity. In the context of pathogenesis, bacterial proteases have been documented to possess key functions such as severing mammalian host immune components, thus rendering them inactive, or degrading host cell membrane proteins and damaging tissues. As increasing numbers of bacterial genomes are being annotated and deposited, mining for under- or unstudied putative proteases can complement the established literature on what is already known and prompt novel investigations into their functions.</p><p>Certain bacterial species are well-known to produce proteases that play significant roles in pathogenesis. <italic>Pseudomonas aeruginosa</italic> is a causative agent of burn wound infections, pneumonia, and ocular infections to name a few, and produces several proteases implicated in direct damage to the host. For example, elastase B causes extensive damage to the cornea during ocular infection [<xref rid="cit0014" ref-type="bibr">14</xref>] and lung injury during pneumonia [<xref rid="cit0015" ref-type="bibr">15</xref>]. Virulence factor studies of <italic>Streptococcus pneumoniae</italic>, on the other hand, have historically focused heavily on the polysaccharide capsule as an antiphagocytic factor and pneumolysin as a multifunctional toxin and mediator belonging to the family of cholesterol-dependent cytolysins. Cell wall-associated proteins, 13&#x02013;16 of which are choline-binding proteins [reviewed in <xref rid="cit0016" ref-type="bibr">16</xref>], have also been studied in the context of adhesion and antigenicity and have shown promise as potential vaccine candidates. Research into <italic>S. pneumoniae</italic> proteases, however, has arguably been less emphasized than other factors until more recently.</p><p>In 1973&#x02013;1974, Johnson demonstrated that <italic>S. pneumoniae</italic> produced a tripeptidase and a dipeptidase which were intracellular or cell-associated and exhibited preferences for methionine residues [<xref rid="cit0017" ref-type="bibr">17</xref>,<xref rid="cit0018" ref-type="bibr">18</xref>]. Five years later, IgA1 protease was identified in <italic>S. pneumoniae</italic> [<xref rid="cit0019" ref-type="bibr">19</xref>,<xref rid="cit0020" ref-type="bibr">20</xref>]. The discovery of other proteases, however, was not highlighted until 1991 when Courtney, who showed that several potential proteases with susceptibilities to different serine protease inhibitors, could cleave fibronectin, elastin, fibrinogen, and laminin [<xref rid="cit0021" ref-type="bibr">21</xref>]. As molecular tools such as next-generation sequencing of bacterial genomes and bioinformatics have progressed over the years, the identification and study of putative pneumococcal proteases has increased and uncovered additional clues as to how this opportunistic pathogen damages host cells/tissues and subverts the immune response. A product of this recent progress is the identification of 34 proteins predicted to be proteases in <italic>S. pneumoniae</italic> TIGR4 using sequence data and protein analysis tools [<xref rid="cit0022" ref-type="bibr">22</xref>]. Herein we aim to provide a current review of <italic>S. pneumoniae</italic> proteases as confirmed or potential virulence factors, exerting their effects either directly on host cells and factors or indirectly via management of bacterial physiology, competence, protein processing, and competition (summarized in <xref rid="t0001" ref-type="table">Table 1</xref>).<table-wrap id="t0001" orientation="landscape" position="float"><label>Table 1.</label><caption><p>Proteases of <italic>S. pneumoniae.</italic></p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/></colgroup><thead><tr><th align="left">Protease/Peptidase Identification (Other Names)</th><th align="center">Genome Locus Tag:*<break/>D39 (new)<break/>D39 (old)<break/>D39V<break/>TIGR4 (new)<break/>TIGR4 (old)</th><th align="center">Function</th><th align="center">Comments</th><th align="center">References</th></tr></thead><tbody><tr><td align="left">ATP-dependent Zinc Protease, putative^</td><td align="left">SPD_RS01695<break/>SPD_0310<break/>SPV_0310<break/>SP_RS01660<break/>SP_0341</td><td align="left">Unknown</td><td align="left">Possesses domains of unknown function</td><td align="left">&#x000a0;</td></tr><tr><td align="left">CbpD</td><td align="left">SPD_RS10730<break/>SPD_2028<break/>SPV_2028<break/>SP_RS11240<break/>SP_2201</td><td align="left">Peptidoglycan hydrolysis</td><td align="left">CHAP domain</td><td align="left"><xref ref-type="bibr" rid="cit0031">31</xref>, <xref ref-type="bibr" rid="cit0032">32</xref></td></tr><tr><td align="left">CbpG</td><td align="left">SPD_RS01935<break/>SPD_0356<break/>SPV_0356<break/>SP_RS01925<break/>SP_0390</td><td align="left">Serine protease; cleaves casein and fibronectin</td><td align="left">Frameshifted in D39; intact in TIGR4; S1 family peptidase [His-Asp-Ser catalytic triad]</td><td align="left"><xref ref-type="bibr" rid="cit0032">32</xref>, <xref ref-type="bibr" rid="cit0034">34</xref></td></tr><tr><td align="left">ClpP</td><td align="left">SPD_RS03495<break/>SPD_0650<break/>SPV_0650<break/>SP_RS03655<break/>SP_0746</td><td align="left">Cleaves proteins tagged for degradation (complex with ClpA or ClpX]</td><td align="left">S14 peptidase family [Ser-His-Asp catalytic triad)</td><td align="left"><xref ref-type="bibr" rid="cit0036">36</xref>; <xref ref-type="bibr" rid="cit0037">37</xref>, <xref ref-type="bibr" rid="cit0038">38</xref>, <xref ref-type="bibr" rid="cit0041 cit0042 cit0043">41&#x02013;43</xref>, <xref ref-type="bibr" rid="cit0045">45</xref>, <xref ref-type="bibr" rid="cit0048 cit0049 cit0050 cit0051 cit0052">48&#x02013;52</xref></td></tr><tr><td align="left">ComA</td><td align="left">SPD_RS00235<break/>SPD_0049<break/>SPV_0049<break/>SP_RS00255<break/>SP_0042</td><td align="left">Cleavage of competence-stimulating peptide at Gly-Gly</td><td align="left">Peptidase C39 family, ABC transporter peptidase subunit</td><td align="left"><xref ref-type="bibr" rid="cit0047">47</xref></td></tr><tr><td align="left">CppA^</td><td align="left">SPD_RS06830<break/>SPD_1278<break/>SPV_1278<break/>SP_RS07120<break/>SP_1449</td><td align="left">Cleavage of complement C3</td><td align="left">Glyoxalase/Bleomycin Resistance Protein/Dihydroxybiphenyl Dioxygenase homologous superfamily of metalloenzymes</td><td align="left"><xref ref-type="bibr" rid="cit0053 cit0054 cit0055 cit0056 cit0057">53&#x02013;57</xref>, <xref ref-type="bibr" rid="cit0098">98</xref></td></tr><tr><td align="left">DacA (D-Alanyl-D-Alanine Carboxypeptidase; Penicillin-binding Protein 3)</td><td align="left">SPD_RS04110<break/>SPD_0767<break/>SPV_0767<break/>SP_RS04300<break/>SP_0872</td><td align="left">Cleavage of D-alanine residues during peptidoglycan synthesis</td><td align="left">Peptidase S11 famly; gene names and synonyms according to D39V annotation: <italic toggle="yes">pbp3, dacA, dacC</italic></td><td align="left"><xref ref-type="bibr" rid="cit0086 cit0087 cit0088">86&#x02013;88</xref></td></tr><tr><td align="left">DacB (LdcB)</td><td align="left">SPD_RS02940<break/>SPD_0549<break/>SPV_0549<break/>SP_RS03085<break/>SP_0629</td><td align="left">L,D-carboxypeptidase; peptidoglycan hydrolysis</td><td align="left">Peptidase M15B family; Hedgehog signaling/DD-peptidase zinc-binding domain superfamily</td><td align="left"><xref ref-type="bibr" rid="cit0086">86</xref>, <xref ref-type="bibr" rid="cit0089 cit0090 cit0091">89&#x02013;91</xref></td></tr><tr><td align="left">FtsH/Yme1/Tma family protein</td><td align="left">SPD_RS00060<break/>SPD_0013<break/>SPV_0013<break/>SP_RS00065<break/>SP_0013</td><td align="left">ATP-dependent metallopeptidase; Cleaves proteins tagged for degradation</td><td align="left">Peptidase M41 carboxyl-terminal domain</td><td align="left">&#x000a0;</td></tr><tr><td align="left">HtpX</td><td align="left">SPD_RS06075<break/>SPD_1138<break/>SPV_1138<break/>SP_RS06290<break/>SP_1283</td><td align="left">Putative stress response protein; zinc metalloprotease</td><td align="left">Peptidase M48 family; contains a conserved zinc-binding HExxH motif found in zinc metalloproteases</td><td align="left">&#x000a0;</td></tr><tr><td align="left">HtrA (DegP)</td><td align="left">SPD_RS10945<break/>SPD_2068<break/>SPV_2068<break/>SP_RS11450<break/>SP_2239</td><td align="left">Serine protease; chaperone</td><td align="left">Peptidase S1C family, protease Do subfamily; PDZ domain [His-Asp-Ser catalytic triad)</td><td align="left"><xref ref-type="bibr" rid="cit0059">59</xref>, <xref ref-type="bibr" rid="cit0060">60</xref>, <xref ref-type="bibr" rid="cit0062 cit0063 cit0064 cit0065 cit0066 cit0067 cit0068 cit0069 cit0070 cit0071 cit0072">62&#x02013;72</xref></td></tr><tr><td align="left">IgA1 Protease (ZmpA)</td><td align="left">SPD_RS05470<break/>SPD_1018<break/>SPV_1018<break/>SP_RS05695<break/>SP_1154</td><td align="left">Zinc metalloprotease</td><td align="left">Contains a conserved zinc-binding HExxH motif found in zinc metalloproteases</td><td align="left"><xref ref-type="bibr" rid="cit0019">19</xref>, <xref ref-type="bibr" rid="cit0020">20</xref>, <xref ref-type="bibr" rid="cit0073 cit0074 cit0075 cit0076 cit0077 cit0078 cit0079 cit0080 cit0081 cit0082 cit0083 cit0084 cit0085">73&#x02013;85</xref></td></tr><tr><td align="left">L,D-Carboxypeptidase (Muramoyltetrapeptide Carboxypeptidase)</td><td align="left">SPD_RS00960<break/>SPD_0173<break/>SPV_0173<break/>SP_RS00905<break/>SP_0182</td><td align="left">Cleavage of the peptidoglycan tetrapeptide</td><td align="left">Peptidase family S66</td><td align="left">&#x000a0;</td></tr><tr><td align="left">LepB (Signal peptidase I)</td><td align="left">SPD_RS01985<break/>SPD_0367<break/>SPV_0367<break/>SP_RS01995<break/>SP_0402</td><td align="left">Serine peptidase; cleaves leader peptide from pro-proteins</td><td align="left">Serine-lysine catalytic dyad</td><td align="left"><xref ref-type="bibr" rid="cit0107">107</xref></td></tr><tr><td align="left">Lon-like Protease, putative^</td><td align="left">SPD_RS09400<break/>SPD_1765<break/>SPV_1765<break/>SP_RS09890<break/>SP_1967</td><td align="left">Degradation of misfolded proteins</td><td align="left">S16 peptidase family; ATP-dependent serine peptidase</td><td align="left">&#x000a0;</td></tr><tr><td align="left">LspA (Signal peptidase II)</td><td align="left">SPD_RS04400<break/>SPD_0819<break/>SPV_0819<break/>SP_RS04590<break/>SP_0928</td><td align="left">Cleaves signal sequence from pro-lipoproteins</td><td align="left">Peptidase A8, signal peptidase II family; recognizes lipobox sequence</td><td align="left"><xref ref-type="bibr" rid="cit0108">108</xref>, <xref ref-type="bibr" rid="cit0109">109</xref></td></tr><tr><td align="left">Matrixin Family Metalloprotease; Putative Zinc-dependent Protease</td><td align="left">SPD_RS02880<break/>SPD_0537<break/>SPV_0537<break/>SP_RS03030<break/>SP_0617</td><td align="left">Unknown</td><td align="left">Peptidase M10 metallopeptidase family; domain matching the zinc metalloprotease MMP-like subfamily</td><td align="left">&#x000a0;</td></tr><tr><td align="left">M42 Family Metallopeptidase</td><td align="left">SPD_RS02930<break/>SPD_0547<break/>SPV_0547<break/>SP_RS03075<break/>SP_0627</td><td align="left">Glutamyl aminopeptidase, PepA type, putative</td><td align="left">Peptidase M42 family</td><td align="left">&#x000a0;</td></tr><tr><td align="left">M50 Family Metallopeptidase</td><td align="left">SPD_RS09330<break/>SPD_1751<break/>SPV_1751<break/>SP_RS09810<break/>SP_1952</td><td align="left">Regulated intramembrane proteolysis (RIP] metalloprotease, putative</td><td align="left">M50 family of putative membrane-associated zinc metalloproteases; contains a conserved zinc-binding HExxH motif; RIP proteases are involved in a two-step process of cleaving transmembrane proteins; site-2 protease class of zinc metalloproteases</td><td align="left">&#x000a0;</td></tr><tr><td align="left">Methionyl Aminopeptidase (MAP)</td><td align="left">SPD_RS05220<break/>SPD_0970<break/>SPV_0970<break/>SP_RS05360<break/>SP_1084</td><td align="left">Cleavage of amino-terminal Met residue</td><td align="left">Peptidase M24A family of metallopeptidases; cobalt required for activity</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PepA</td><td align="left">SPD_RS08780<break/>SPD_1647<break/>SPV_1647<break/>SP_RS09255<break/>SP_1865</td><td align="left">Glutamyl aminopeptidase</td><td align="left">Peptidase M42 family</td><td align="left"><xref ref-type="bibr" rid="cit0058">58</xref></td></tr><tr><td align="left">PepC</td><td align="left">SPD_RS01425<break/>SPD_0261<break/>SPV_0261<break/>SP_RS01380<break/>SP_0281</td><td align="left">Aminopeptidase</td><td align="left">Peptidase C1 family; homologous superfamily of papain-like cysteine peptidases</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PepF (PepB, PepF1)#</td><td align="left">SPD_RS04660<break/>SPD_0866<break/>SPV_0866<break/>SP_RS04855<break/>SP_0979</td><td align="left">Oligoendopeptidase</td><td align="left">Peptidase M3B family</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PepF (PepF2)#</td><td align="left">SPD_RS08365<break/>SPD_1571<break/>SPV_1571<break/>SP_RS08835<break/>SP_1780</td><td align="left">Oligoendopeptidase</td><td align="left">Peptidase M3B family</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PepN</td><td align="left">SPD_RS03770<break/>SPD_0700<break/>SPV_0700<break/>SP_RS03900<break/>SP_0797</td><td align="left">Lysyl aminopeptidase</td><td align="left">M1 family metallopeptidase</td><td align="left"><xref ref-type="bibr" rid="cit0023 cit0024 cit0025">23&#x02013;25</xref></td></tr><tr><td align="left">PepO</td><td align="left">SPD_RS07765<break/>SPD_1460<break/>SPV_1460<break/>SP_RS08130<break/>SP_1647</td><td align="left">Endopeptidase</td><td align="left">M13 peptidase family</td><td align="left"><xref ref-type="bibr" rid="cit0092">92</xref>, <xref ref-type="bibr" rid="cit0093">93</xref>, <xref ref-type="bibr" rid="cit0095 cit0096 cit0097">95&#x02013;97</xref></td></tr><tr><td align="left">PepP (YpdF)</td><td align="left">SPD_RS00980<break/>SPD_0177<break/>SPV_0177<break/>SP_RS00925<break/>SP_0187</td><td align="left">Aminopeptidase</td><td align="left">Described as MP-,MA-,MS-,AP-,NP-specific aminopeptidase YpdF by D39V annotation</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PepQ</td><td align="left">SPD_RS07540<break/>SPD_1418<break/>SPV_1418<break/>SP_RS07840<break/>SP_1591</td><td align="left">Proline dipeptidase</td><td align="left">Peptidase M24 family; creatinase/aminopeptidase P amino-terminal domain</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PepS</td><td align="left">SPD_RS01405<break/>SPD_0258<break/>SPV_0258<break/>SP_RS01355<break/>SP_0278</td><td align="left">Aminopeptidase</td><td align="left">Peptidase M29 family of metallopeptidases</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PepT</td><td align="left">SPD_RS04810<break/>SPD_0894<break/>SPV_0894<break/>SP_RS05000<break/>SP_1008</td><td align="left">Tripeptide aminopeptidase</td><td align="left">Described as a tripeptide aminopeptidase by D39V annotation</td><td align="left">&#x000a0;</td></tr><tr><td align="left">Peptidase C39</td><td align="left">SPD_RS10955<break/>&#x02013; -<break/>&#x02013; -<break/>SP_RS02605<break/>&#x02013; -</td><td align="left">Bacteriocin processing, putative</td><td align="left">Incomplete in D39</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PepV</td><td align="left">SPD_RS02905<break/>SPD_0542<break/>SPV_0542<break/>SP_RS03055<break/>SP_0623</td><td align="left">Dipeptidase</td><td align="left">Described as most specific for beta-Ala-Xaa by D39V annotation</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PepX (Xaa-Pro Dipeptidyl-Peptidase)</td><td align="left">SPD_RS04205<break/>SPD_0787<break/>SPV_0787<break/>SP_RS04410<break/>SP_0894</td><td align="left">Cleavage of Xaa-Pro dipeptides (Xaa&#x000a0;=&#x000a0;a hydrophobic amino acid)</td><td align="left">Peptidase S15 family of serine peptidases</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PhtA (PhpA)</td><td align="left">SPD_RS05575<break/>SPD_1038<break/>SPV_1038<break/>SP_RS05790<break/>SP_1175</td><td align="left">Cleavage of complement C3</td><td align="left">Histidine triad HxxHxH motif</td><td align="left"><xref ref-type="bibr" rid="cit0053">53</xref>, <xref ref-type="bibr" rid="cit0098 cit0099 cit0100 cit0101 cit0102">98&#x02013;102</xref></td></tr><tr><td align="left">Prp</td><td align="left">SPD_RS05320<break/>SPD_0990<break/>SPV_0990<break/>SP_RS05480<break/>SP_1106</td><td align="left">Cleavage of bacterial ribosomal protein L27</td><td align="left">PrP family of cysteine proteases; putative His-Cys catalytic dyad</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PrsW</td><td align="left">SPD_RS00150<break/>SPD_0031<break/>SPV_2079<break/>SP_RS00170<break/>SP_0026</td><td align="left">Intramembrane metalloprotease</td><td align="left">PrsW family possibly involved in cell membrane stress response; frameshifted in D39</td><td align="left">&#x000a0;</td></tr><tr><td align="left">PrtA</td><td align="left">SPD_RS03010<break/>SPD_0558<break/>SPV_0558<break/>SP_RS03145<break/>SP_0641</td><td align="left">Serine peptidase; cleavage of leader peptides from lantibiotics</td><td align="left">S8 family of lantibiotic leader peptide-processing serine proteases; [Asp-His-Ser catalytic triad sequence]</td><td align="left"><xref ref-type="bibr" rid="cit0060">60</xref>, <xref ref-type="bibr" rid="cit0103 cit0104 cit0105 cit0106">103&#x02013;106</xref></td></tr><tr><td align="left">PtrB (Protease II)</td><td align="left">SPD_RS06300<break/>SPD_1178<break/>SPV_1178<break/>SP_RS06590<break/>SP_1343</td><td align="left">Serine peptidase</td><td align="left">S9 family peptidase (Ser-Asp-His catalytic triad sequence), usually cleaves oligopeptides</td><td align="left">&#x000a0;</td></tr><tr><td align="left">Pyroglutamyl Peptidase I (Pcp1)</td><td align="left">SPD_RS04040<break/>SPD_0753<break/>SPV_0753<break/>SP_RS04215<break/>SP_0860</td><td align="left">Cleavage of pyroglutamic acid from peptides or proteins</td><td align="left">Peptidase family C15</td><td align="left">&#x000a0;</td></tr><tr><td align="left">Pyroglutamyl Peptidase I (Pcp2)</td><td align="left">SPD_RS09930<break/>SPD_1870<break/>SPV_1870<break/>SP_RS10415<break/>SP_2060</td><td align="left">Cleavage of pyroglutamic acid from peptides or proteins</td><td align="left">Peptidase family C15; frameshifted in D39</td><td align="left">&#x000a0;</td></tr><tr><td align="left">Rhomboid Family Intramembrane Serine Protease</td><td align="left">SPD_RS10170<break/>SPD_1920<break/>SPV_1920<break/>SP_RS10665<break/>SP_2094</td><td align="left">Intramembrane cleavage of proteins or peptides</td><td align="left">Peptidase S54 domain; (Ser-His catalytic dyad)</td><td align="left">&#x000a0;</td></tr><tr><td align="left">RseP (Eep, RasP, RseP, YluC)</td><td align="left">SPD_RS01335<break/>SPD_0245<break/>SPV_0245<break/>SP_RS01290<break/>SP_0263</td><td align="left">Regulated intramembrane proteolysis [RIP) metalloprotease</td><td align="left">M50 family of putative membrane-associated zinc metalloproteases; contains a conserved zinc-binding HExxH motif; PDZ domain; RIP proteases are involved in a two-step process of cleaving transmembrane proteins</td><td align="left"><xref ref-type="bibr" rid="cit0033">33</xref></td></tr><tr><td align="left">S8 Family Serine Peptidase</td><td align="left">SPD_RS09340<break/>SPD_1753<break/>SPV_1753<break/>SP_RS09820<break/>SP_1954</td><td align="left">Serine peptidase; cleavage of leader peptides from lantibiotics</td><td align="left">S8 family of lantibiotic leader peptide-processing serine proteases; (Asp-His-Ser catalytic triad sequence];<break/>described as epidermin leader peptide processing serine protease EPIP precursor by D39V annotation; frameshifted in TIGR4</td><td align="left">&#x000a0;</td></tr><tr><td align="left">Sapep Family Mn<sup>2+</sup>-dependent Dipeptidase/Xaa-His Dipeptidase</td><td align="left">SPD_RS10475<break/>SPD_1979<break/>SPV_1979<break/>SP_RS10975<break/>SP_2153</td><td align="left">Cleavage of Xaa-His dipeptides (Xaa&#x000a0;=&#x000a0;a hydrophobic amino acid)</td><td align="left">Peptidase M20 family, subfamily M20C; exopeptidase dimerization domain; zinc peptidase domain</td><td align="left">&#x000a0;</td></tr><tr><td align="left">Site-2 Protease Family Protein; Putative Peptidase M50</td><td align="left">SPD_RS08385<break/>SPD_1575<break/>SPV_1575<break/>SP_RS08855<break/>SP_1784</td><td align="left">Metalloprotease; cleavage of protein transmembrane domains; RIP protease</td><td align="left">M50 family of putative membrane-associated zinc metalloproteases; contains a conserved zinc-binding HExxH motif; RIP proteases are involved in a two-step process of cleaving transmembrane proteins</td><td align="left">&#x000a0;</td></tr><tr><td align="left">SprT Family Metalloprotease, putative^</td><td align="left">SPD_RS04300<break/>&#x02013; &#x02013;<break/>SPV_2244<break/>SP_RS04490<break/>SP_0909</td><td align="left">Zinc metalloprotease</td><td align="left">Contains a conserved zinc-binding HExxH motif found in zinc metalloproteases; locus tag not present in D39 accession number CP000410.2</td><td align="left">&#x000a0;</td></tr><tr><td align="left">Type IV Prepilin Peptidase, putative</td><td align="left">SPD_RS08500<break/>SPD_1593<break/>SPV_1593<break/>SP_RS08975<break/>SP_1808</td><td align="left">Cleavage of leader peptide from type IV prepilin-like proteins</td><td align="left">Gene names and synonyms according to D39V annotation: <italic toggle="yes">cclA, cilC, pilD</italic></td><td align="left">&#x000a0;</td></tr><tr><td align="left">U32 Family Peptidase</td><td align="left">SPD_RS03790<break/>SPD_0704<break/>SPV_0704<break/>SP_RS03920<break/>SP_0801</td><td align="left">Unknown</td><td align="left">Diverse family with unknown catalytic mechanisms</td><td align="left">&#x000a0;</td></tr><tr><td align="left">U32 Family Peptidase</td><td align="left">SPD_RS06710<break/>SPD_1256<break/>SPV_1256<break/>SP_RS07000<break/>SP_1427</td><td align="left">Unknown</td><td align="left">Diverse family with unknown catalytic mechanisms; noted as incomplete sequence in D39 but not in D39V; incomplete sequence in TIGR4; D39V annotation indicates SPV_1256 to encode a large C1 subunit</td><td align="left">&#x000a0;</td></tr><tr><td align="left">U32 Family Peptidase</td><td align="left">SPD_RS06720<break/>SPD_1258<break/>SPV_1258<break/>SP_RS07010<break/>SP_1429</td><td align="left">Unknown</td><td align="left">Diverse family with unknown catalytic mechanisms; D39V annotation indicates SPV_1258 to encode a large C1 subunit</td><td align="left">&#x000a0;</td></tr><tr><td align="left">YdiL</td><td align="left">SPD_RS01935<break/>&#x02013; -<break/>SPV_2157<break/>SP_RS02120<break/>SP_0430</td><td align="left">Putative membrane peptidase, hypothetical protein</td><td align="left">TIGR4 protein sequence does not indicate homology to any protease or peptidase families; frameshifted in D39</td><td align="left">&#x000a0;</td></tr><tr><td align="left">YhfC Family Intramembrane Metalloprotease</td><td align="left">SPD_RS06540<break/>SPD_1223<break/>SPV_1223<break/>SP_RS06820<break/>SP_1391</td><td align="left">Metalloprotease</td><td align="left">Intramembrane metalloprotease YhfC<break/>Family; possess a consensus signature and two additional conserved motifs</td><td align="left">&#x000a0;</td></tr><tr><td align="left">Zinc Protease (Insulinase Family Protein)^</td><td align="left">SPD_RS10855<break/>SPD_2052<break/>SPV_2052<break/>SP_RS11360<break/>SP_2225</td><td align="left">Metallopeptidase</td><td align="left">M16 family peptidase (requires a divalent cation such as zinc)</td><td align="left">&#x000a0;</td></tr><tr><td align="left">ZmpB</td><td align="left">SPD_RS03120<break/>SPD_0577<break/>SPV_0577<break/>SP_RS03260<break/>SP_0664</td><td align="left">Zinc metalloprotease</td><td align="left">Contains a conserved zinc-binding HExxH motif found in zinc metalloproteases</td><td align="left"><xref ref-type="bibr" rid="cit0028">28</xref>, <xref ref-type="bibr" rid="cit0084">84</xref>, <xref ref-type="bibr" rid="cit0105">105</xref>, <xref ref-type="bibr" rid="cit0110">110</xref>, <xref ref-type="bibr" rid="cit0112">112</xref>, <xref ref-type="bibr" rid="cit0113">113</xref>, <xref ref-type="bibr" rid="cit0114">114</xref>; <xref ref-type="bibr" rid="cit0111">111</xref>,</td></tr><tr><td align="left">ZmpC</td><td align="left">&#x02013; -<break/>&#x02013; -<break/>&#x02013; -<break/>SP_RS00380<break/>SP_0071</td><td align="left">Zinc metalloprotease</td><td align="left">Not present in D39; Contains a conserved zinc-binding HExxH motif found in zinc metalloproteases</td><td align="left"><xref ref-type="bibr" rid="cit0110">110</xref>, <xref ref-type="bibr" rid="cit0115 cit0116 cit0117">115&#x02013;117</xref>, <xref ref-type="bibr" rid="cit0119">119</xref>, <xref ref-type="bibr" rid="cit0120">120</xref>, <xref ref-type="bibr" rid="cit0118">118</xref></td></tr><tr><td align="left">ZmpD</td><td align="left">&#x02013; -<break/>&#x02013; -<break/>&#x02013; -<break/>&#x02013; -<break/>&#x02013; -</td><td align="left">Zinc metalloprotease</td><td align="left">Not present in D39 or TIGR4; Contains a conserved zinc-binding HExxH motif found in zinc metalloproteases</td><td align="left"><xref ref-type="bibr" rid="cit0027">27</xref>, <xref ref-type="bibr" rid="cit0110">110</xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p>* National Center for Biotechnology Information (NCBI] gene/nucleotide accession numbers for strains D39 [<xref rid="cit0122" ref-type="bibr">122</xref>] with new locus tags, D39 with old locus tags, D39V [<xref rid="cit0124" ref-type="bibr">124</xref>], TIGR4 [<xref rid="cit0123" ref-type="bibr">123</xref>] with new locus tags, and TIGR4 with old locus tags are NC_008533.2, CP000410.2, CP027540.1, NC_003028.3, and AE005672.3, respectively.</p></fn><fn id="tfn0002"><p>#The D39 and TIGR4 annotations list two genes as <italic>pepF</italic>. The D39V annotation distinguishes these genes as <italic>pepF1</italic> and <italic>pepF2</italic>. Both gene products are approximately 600 amino acids but only share 24% identity in the D39 background.</p></fn><fn id="tfn0003"><p>^These locus tags were identified as encoding proteins with putative protease activity by the deep annotation method employed for D39V [<xref rid="cit0124" ref-type="bibr">124</xref>].</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="s0003" disp-level="1"><title>Aminopeptidase N (PepN)</title><p>PepN is a lysyl peptidase that is localized to the bacterial cell wall but does not possess an LPXTG motif [<xref rid="cit0023" ref-type="bibr">23</xref>]. PepN has an inhibitory effect on T cell receptor signaling; however, this inhibition is not due to protease activity by PepN [<xref rid="cit0024" ref-type="bibr">24</xref>]. <italic>S. pneumoniae</italic> deficient in PepN are reduced in nasopharyngeal colonization in mice, reduced in adhesion and invasion of lung A549 cells, cause reduced inflammation in mouse lungs, and cause reduced production of inflammatory cytokines in vivo [<xref rid="cit0025" ref-type="bibr">25</xref>]. It is unclear whether the peptidase function of PepN contributes to the effects. PepN belongs to the peptidase M1-type family. Interestingly, PepN possesses an endoplasmic reticulum aminopeptidase 1-like (ERAP1-like) carboxyl-terminal domain that has been linked to pathways involved not only in metabolism but also in immune functions.</p></sec><sec id="s0004" disp-level="1"><title>CAAX Proteases and Bacteriocin-Processing (CPBP) Family Intramembrane Metalloproteases, and Sortases</title><p><italic>S. pneumoniae</italic> possesses numerous putative intramembrane proteases that are related to eukaryotic CAAX enzymes, which are prenyl proteases in the endoplasmic reticulum membrane that cleave CAAX motifs from their respective substrates. For the purpose of brevity, the locus tags for all of these putative proteases are omitted from <xref rid="t0001" ref-type="table">Table 1</xref>. A review of these proteases is described by <xref rid="cit0026" ref-type="bibr">26</xref>. In short, the CAAX proteases in eukaryotes are involved in the attachment of lipids to proteins, allowing the proteins to be membrane-embedded. In bacteria, the related CPBP proteases are somewhat similar to PrsW (&#x0201c;protease responsible for activating sigma factor W;&#x0201d; <xref rid="t0001" ref-type="table">Table 1</xref>), with general function of regulated intramembrane proteolysis (RIP) as is listed for RseP (&#x0201c;regulator of sigma-E protease;&#x0201d; described in the next section).</p><p>Sortases, which act as membrane-localized proteases and transpeptidases, typically recognize the LPXTG motifs on proteins that are to be transported and displayed on the bacterial cell surface. Cleavage usually occurs at the carboxyl-terminus of the target protein, although the LPXTG motif is located on the amino-termini of some proteins such as IgA1 protease, zinc metalloprotease B (ZmpB), ZmpC, and ZmpD [<xref rid="cit0027" ref-type="bibr">27</xref>]. Sortases have been reviewed elsewhere [<xref rid="cit0029" ref-type="bibr">29</xref>].</p></sec><sec id="s0005" disp-level="1"><title>Choline-binding Protein D (CbpD) and Regulator of Sigma-E Protease (RseP)</title><p>CbpD is a protein that is covalently bound to the phosphorylcholine residues on the cell wall teichoic acids of <italic>S. pneumoniae</italic>. This protein possesses a cysteine, histidine-dependent amidohydrolase/peptidase (CHAP) domain and is responsible in part for peptidoglycan-mediated lysis of subpopulations of pneumococci which results in the release of DNA that can be taken up by neighboring <italic>S. pneumoniae</italic>. Although other pneumococcal proteins are also involved in bacterial cell lysis (LytA for example), the active site cysteine of the CbpD CHAP domain has been determined to be required for lysis, suggesting that the lytic function is dependent on protease/peptidase activity [<xref rid="cit0031" ref-type="bibr">31</xref>]. Lysis of neighboring bacteria, which has been popularly coined microbial fratricide, serves an important function in virulence. Elimination of non-competent bacteria in a population reduces competition for nutrients by the remaining bacteria, improving fitness and survival which are tied to pathogenesis. Moreover, DNA release and subsequent uptake by the remaining pneumococci can introduce new virulence-associated genes to the chromosome. Aside from its role in bacterial lysis, CbpD may possess other virulence functions. <italic>S. pneumoniae</italic> deficient in CbpD are significantly less effective at nasopharyngeal colonization, although the mechanism by which CbpD contributes to colonization is unknown [<xref rid="cit0032" ref-type="bibr">32</xref>].</p><p>Related to the ability of CbpD to cause bacterial cell lysis is another pneumococcal protease, the regulated intramembrane proteolysis (RIP) metalloprotease RseP (&#x0201c;regulator of sigma-E,&#x0201d; as named in <italic>Escherichia coli</italic> for its role in activating stress response sigma factors), also known as enhanced expression of pheromone protein (Eep) and other aliases. This intramembrane protease cleaves ComM, a competence protein that is situated in the cell membrane and protects competent <italic>S. pneumoniae</italic> from CbpD-mediated lysis. Unregulated quantities of ComM cause pneumococcal cell shape abnormalities and growth defects; RseP (along with other unidentified factors) controls the quantity of ComM [<xref rid="cit0033" ref-type="bibr">33</xref>].</p></sec><sec id="s0006" disp-level="1"><title>Choline-binding Protein G (CbpG)</title><p>According to European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI) InterPro tool analysis of GenBank protein accession number AAF87770.1, CbpG is a trypsin-like serine protease of the peptidase S1, PA clan superfamily of peptidases. CbpG protein sequence indicates that this protein possesses a chymotrypsin-like fold and double beta-barrel structure with a carboxyl-terminal choline-binding domain. An <italic>S. pneumoniae</italic> CbpG-negative mutant exhibited only 25% of wild type ability to colonize the rat nasopharynx, a reduced adherence to nasopharyngeal cells <italic>in vitro</italic>, and a significant reduction in virulence (0% mortality) in infant rat septicemia [<xref rid="cit0032" ref-type="bibr">32</xref>]. The specific mode of action of CbpG in its contribution to adherence and colonization requires that CbpG is in its bacterial surface-bound form via the carboxyl-terminal choline-binding domain [<xref rid="cit0034" ref-type="bibr">34</xref>]. The protease portion of CbpG cleaves casein and fibronectin, and enzyme activity remains intact regardless of the presence or absence of the choline-binding domain [<xref rid="cit0034" ref-type="bibr">34</xref>]. The truncated form of CbpG is released from the bacterial cell and retains protease activity. To date, it is unclear whether the protease activity of the amino-terminal portion plays a role in mediating adherence to host cells, or whether part or all of the amino-terminal portion can provide the adherence link despite the presence of protease. Although the specific mechanism of the proteolytic activity has not been defined at the molecular level in pathogenesis, the observation that the amino-terminal protease-containing domain of CbpG is important for adherence warrants additional investigation. However, a role for this domain in invasive disease is not supported, as truncated CbpG mutants expressing the protease domain but deleted in the choline-binding domain are attenuated [<xref rid="cit0034" ref-type="bibr">34</xref>].</p></sec><sec id="s0007" disp-level="1"><title>Caseinolytic Protease P (ClpP)</title><p>Clp proteins constitute complexes that use ATP hydrolysis to drive the processing and degradation of misfolded or otherwise defective proteins. Thus, Clp proteins are essential to maintaining homeostasis. Most are part of the heat shock protein 100 (Hsp100) family of stress response proteins, and are also present in plants and animals. Some of these proteins, such as ClpA and ClpX, are the ATP-binding subunits with ATPase activity and recognize protein targets tagged for degradation. ClpA or ClpX (as well as other Clp proteins) can complex with ClpP to form ClpAP or ClpXP protease. The protein constituent of the protease that possesses the enzymatic activity is ClpP, a cytoplasmic serine protease of the S14 peptidase family (MEROPS accession number MER0000474). The active site of ClpP is in the order of serine-histidine-aspartate, a characteristic unique to this family. Individual ClpP proteins assemble to form a homotetradecameric channel through which faulty proteins are transported and cut.</p><p>ClpP is required for adherence of <italic>S. pneumoniae</italic> to A549 lung cells in vitro. Pre-incubation of pneumococci with anti-ClpP antibody reduced adherence to A549 cells by over 50% [<xref rid="cit0036" ref-type="bibr">36</xref>]. Whether the reduced adherence is due to blocking a direct interaction of ClpP with the host cell, or causing a ClpP-mediated effect on another unknown pneumococcal protein essential for adherence, is unclear. ClpP is also important for uptake of pneumococci by dendritic cells (DCs) and for pneumococcal survival within activated macrophages [<xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0038" ref-type="bibr">38</xref>]. Wild type pneumococci induce apoptosis of DCs whereas <italic>clpP</italic> mutant pneumococci are significantly abrogated in induction of apoptosis. Again, whether this virulence characteristic of ClpP is directly owing to the enzymatic activity of ClpP, or is a result of other proteins that were affected by ClpP proteolytic processing, is unknown [<xref rid="cit0037" ref-type="bibr">37</xref>]. Regardless, both active and passive immunization with ClpP is highly protective against invasive <italic>S. pneumoniae</italic> disease [<xref rid="cit0036" ref-type="bibr">36</xref>,<xref rid="cit0039" ref-type="bibr">39</xref>]. The ability to target ClpP as a successful means to protect the host indicates that ClpP is a virulence factor, probably by virtue of its function in maintaining bacterial cell homeostasis through misfolded or defective protein degradation.</p><p>The <italic>comCDE</italic> operon encodes genes required for pneumococcal competence, notably the production of the competence-stimulating peptide and recognition of that peptide to induce a signal transduction cascade resulting in the increased ability to take up donor DNA [<xref rid="cit0040" ref-type="bibr">40</xref>]. Genetic disruption of <italic>clpP</italic> causes overexpression of the <italic>comCDE</italic> operon [<xref rid="cit0041" ref-type="bibr">41</xref>,<xref rid="cit0042" ref-type="bibr">42</xref>]. This finding suggests that ClpP is involved in the down-regulation of competence, which was confirmed in transcription repression studies that also demonstrated the necessity for the ClpX ATPase [<xref rid="cit0043" ref-type="bibr">43</xref>]. The direct connection between the proteolytic activity of ClpP and regulation of competence has been demonstrated in <italic>Bacillus subtilis</italic>, in which ClpP degrades the transcription factor ComK [<xref rid="cit0044" ref-type="bibr">44</xref>]. It has also been hypothesized that ClpP is responsible for the degradation of ComX, the sigma factor involved in competence [<xref rid="cit0045" ref-type="bibr">45</xref>]. An interesting similarity between the competence system and the Clp protein complexes is that the <italic>comA</italic> and <italic>comB</italic> gene products form an ATP-binding cassette transporter complex. ComAB recognizes and cleaves the pre-peptide from the competence-stimulating peptide and transports the mature peptide outside the cell [<xref rid="cit0030" ref-type="bibr">30</xref>, <xref rid="cit0046" ref-type="bibr">46</xref>]. ComA is the peptidase in the complex, cleaving at a glycine doublet via its amino-terminal peptidase domain which belongs to the family of cysteine proteases [<xref rid="cit0047" ref-type="bibr">47</xref>].</p><p>ClpP is required for nasopharyngeal colonization, lung infection, and systemic disease in several mouse models of pneumococcal infection using ClpP-negative strains and their parental counterparts. These models included inoculation by intratracheal, intraperitoneal, intravenous, and intranasal routes [<xref rid="cit0038" ref-type="bibr">38</xref>,<xref rid="cit0042" ref-type="bibr">42</xref>,<xref rid="cit0048" ref-type="bibr">48</xref>,<xref rid="cit0049" ref-type="bibr">49</xref>]. Immunization with ClpP increased the survival time of mice infected intraperitoneally with <italic>S. pneumoniae</italic> [<xref rid="cit0049" ref-type="bibr">49</xref>] and provided protection in conjunction with two other pneumococcal proteins in mouse pneumonia and sepsis models [<xref rid="cit0050" ref-type="bibr">50</xref>]. ClpP causes apoptosis of neuroblastoma cells [<xref rid="cit0051" ref-type="bibr">51</xref>]. Interestingly, however, <italic>clpP</italic> has reduced expression in lung and pleural fluid during pneumococcal respiratory infection in mice [<xref rid="cit0052" ref-type="bibr">52</xref>]. Conversely, an increase in expression was quantified for <italic>comB</italic>, one of the two genes encoding the transport apparatus for competence-stimulating peptide ComC. These findings further strengthen the idea that ClpP represses competence [<xref rid="cit0052" ref-type="bibr">52</xref>], although it remains speculative whether a direct cleavage event by ClpP is involved in competence inhibition.</p></sec><sec id="s0008" disp-level="1"><title>C3-degrading Protease CppA</title><p>Degradation of human complement component C3 by <italic>S. pneumoniae</italic> was demonstrated to be independent of capsule type and likely the result of one or more cell wall-associated proteases produced by the bacterium [<xref rid="cit0053" ref-type="bibr">53</xref>]. Since the discovery of C3 cleavage, at least two pneumococcal proteins have been implicated as having proteolytic activity against this complement constituent. These proteins are CppA and PhtA (PhtA to be discussed later). The direct linkage of C3-degrading activity being attributable specifically to CppA is difficult to find in the standard scientific literature; however, the proteolytic activity has been reported in a patent [<xref rid="cit0054" ref-type="bibr">54</xref>]. Nearly the entire sequence of CppA matches to the glyoxalase/bleomycin resistance protein/dihydroxybiphenyl dioxygenase type superfamily of proteins, which contain beta-alpha-beta(3) motifs characteristic of various types of enzymes with affinities for metal ions [<xref rid="cit0055" ref-type="bibr">55</xref>,<xref rid="cit0061" ref-type="bibr">61</xref>]. The gene encoding CppA was determined to be required for fitness of <italic>S. pneumoniae</italic> in the blood of wild-type mice, but nonessential in sickle cell disease mice [<xref rid="cit0056" ref-type="bibr">56</xref>]. These findings were further confirmed when immunization with CppA protected wild type mice but not sickle cell mice [<xref rid="cit0056" ref-type="bibr">56</xref>]. Additionally, CppA was shown to be required for nasopharyngeal transmission in animal models [<xref rid="cit0057" ref-type="bibr">57</xref>], although it is unknown whether the protease function, or some other attribute, of this protein is involved in transmission.</p></sec><sec id="s0009" disp-level="1"><title>Glutamyl Aminopeptidase A (PepA)</title><p>PepA is a cytosolic aminopeptidase with preference for glutamate and aspartate residues [<xref rid="cit0058" ref-type="bibr">58</xref>]. Sequence analysis of PepA indicates that it belongs to the M42 family of peptidases, members of which have roles in metabolism and amino acid biosynthesis [<xref rid="cit0061" ref-type="bibr">61</xref>]. Whether PepA possesses a functional role in virulence is not yet known.</p></sec><sec id="s0010" disp-level="1"><title>High Temperature Requirement A (HtrA; also DegP)</title><p>HtrA is a trypsin-like protease of the peptidase S1C family, protease Do subfamily. Proteases of this family, including HtrA, possess a middle trypsin-like serine protease domain and one or more carboxyl-terminal PSD-95/Dlg/ZO-1 (PDZ) domains that are responsible for substrate protein recognition and/or binding [<xref rid="cit0061" ref-type="bibr">61</xref>]. HtrA is homologous to the Degradation of Periplasmic Proteins (Deg) proteases in <italic>E. coli</italic>, which serve as stress response chaperones and proteases [<xref rid="cit0059" ref-type="bibr">59</xref>]. The presence of a putative amino-terminal signal peptide indicates that HtrA is located on the surface and/or secreted from <italic>S. pneumoniae</italic> [<xref rid="cit0060" ref-type="bibr">60</xref>]. HtrA functions as a molecular chaperone at normal temperatures (28 &#x000b0;C to 37 &#x000b0;C) and as a protease at higher temperatures such as 42 &#x000b0;C [<xref rid="cit0062" ref-type="bibr">62</xref>]. HtrA cleaves non-native derivatives of penicillin-binding protein 2x, a cell wall protein [<xref rid="cit0063" ref-type="bibr">63</xref>], and is important for protection against oxidative stress [<xref rid="cit0064" ref-type="bibr">64</xref>].</p><p>The role that HtrA plays in pneumococcal competence is complicated by apparent conflicting results. In one case, <italic>S. pneumoniae</italic> deficient in HtrA were significantly reduced in transformation efficiency, suggesting that HtrA was necessary for competence [<xref rid="cit0064" ref-type="bibr">64</xref>]. In another case, deletion of most of <italic>htrA</italic> or mutation of its putative catalytic residue, had no effect on competence [<xref rid="cit0065" ref-type="bibr">65</xref>]. However, the mutation methods as well as the transformation conditions were different between these two studies. HtrA degrades competence-stimulating peptide [<xref rid="cit0066" ref-type="bibr">66</xref>], although addition of abundant exogenous competence-stimulating peptide does not restore competence [<xref rid="cit0065" ref-type="bibr">65</xref>]. As described above, the competence-stimulating peptide elicits transformation in <italic>S. pneumoniae</italic> as part of a network of competence-related genes [<xref rid="cit0040" ref-type="bibr">40</xref>]. The specificity of HtrA for the competence-stimulating peptide lies at a phenylalanine (nonpolar) residue, and addition of denatured but not intact bovine serum albumin blocks cleavage of the peptide [<xref rid="cit0066" ref-type="bibr">66</xref>]. The complexity surrounding the function of HtrA in competence may be dissected by examination of the temporal nature of competence proteins. <italic>S. pneumoniae</italic> cells in a competent state experience significant decreases in almost all of the competence-related proteins over time, then a stabilization of these proteins [<xref rid="cit0067" ref-type="bibr">67</xref>]. Exceptions to this stabilization are two of the competence protein complexes, ComEA and ComEC, which constitute major membrane components that bind and take up donor DNA. These proteins are nearly depleted by the end of competence [<xref rid="cit0067" ref-type="bibr">67</xref>]. Mutants deficient in HtrA, while significantly reduced in transformation efficiency as was shown previously [<xref rid="cit0064" ref-type="bibr">64</xref>], did not experience ComEA or ComEC degradation, suggesting that HtrA degrades these proteins late in competence [<xref rid="cit0067" ref-type="bibr">67</xref>]. HtrA appears to perform its regulatory function depending upon bacterial culture conditions, as this protease suppresses competence in rich complex medium but not in a chemically-defined medium [<xref rid="cit0068" ref-type="bibr">68</xref>]. Collectively, these studies suggest that HtrA performs the role of a competence regulator at the protein level and that regulation depends in part upon environmental conditions. This idea is supported by the finding that HtrA, specifically its proteolytic active site serine residue, is not able to inhibit competence when coding errors are increased during protein synthesis [<xref rid="cit0069" ref-type="bibr">69</xref>].</p><p>In addition to its role in competence, HtrA appears to regulate bacteriocin production. Opaque variants of <italic>S. pneumoniae</italic> produce the bacteriocin, pneumocin MN, whereas transparent variants do not [<xref rid="cit0070" ref-type="bibr">70</xref>]. Opaque variants produce four-fold less message for <italic>htrA</italic>. Deletion of <italic>htrA</italic> in the transparent variants caused an increase in pneumocin MN production. Control of pneumocin MN production by HtrA is accomplished by HtrA limiting the processing and secretion of the bacteriocin peptide pheromone, bacteriocin-like peptide C (BlpC) [<xref rid="cit0071" ref-type="bibr">71</xref>]. Neighboring bacteria sense BlpC, which binds to the histidine kinase BlpH, inducing transcription of the genes in the <italic>blp</italic> locus and resulting in pneumocin MN production; if BlpC export is controlled or limited, then sensing by neighbors and therefore pneumocin MN production is limited [<xref rid="cit0071" ref-type="bibr">71</xref>].</p><p>Although HtrA had been well-studied in other species, <italic>S. pneumoniae</italic>-specific HtrA was not documented until less than 20&#x000a0;years ago, when it was identified as having reduced expression in a strain deficient in competence induction and altered cefotaxime susceptibility response regulator/histidine kinase (CiaRH), the two-component signal transduction system which regulates <italic>htrA</italic> [<xref rid="cit0072" ref-type="bibr">72</xref>]. HtrA was further determined to be the CiaRH-controlled protein important for nasopharyngeal colonization [<xref rid="cit0072" ref-type="bibr">72</xref>]. HtrA is important for virulence in mouse pneumonia. Mutants had reduced or nil bacterial loads in lung, blood, spleen, and liver. Likewise, <italic>htrA</italic> mutants caused reduced inflammatory cytokine levels in lung, reduced lung infiltrate, and increased survival [<xref rid="cit0060" ref-type="bibr">60</xref>,<xref rid="cit0064" ref-type="bibr">64</xref>].</p></sec><sec id="s0011" disp-level="1"><title>Immunoglobulin A1 (IgA1) Protease</title><p>The <italic>S. pneumoniae</italic> IgA1 protease was discovered in 1979 and shown to cleave IgA1 but not IgA2 or other immunoglobulins [<xref rid="cit0019" ref-type="bibr">19</xref>,<xref rid="cit0020" ref-type="bibr">20</xref>]. It was proposed to play a role in mucosal attachment to host cells based on IgA protease activity comparisons between strains isolated from asymptomatic individuals and patients with invasive <italic>S. pneumoniae</italic> infections [<xref rid="cit0073" ref-type="bibr">73</xref>]. IgA1 protease is a cell wall-associated metalloprotease which can be released during late stationary phase of <italic>S. pneumoniae</italic> [<xref rid="cit0074" ref-type="bibr">74</xref>,<xref rid="cit0075" ref-type="bibr">75</xref>]. This protease contains a conserved zinc-binding HExxH motif found in zinc metalloproteases, toward the carboxyl-terminus [<xref rid="cit0075" ref-type="bibr">75</xref>,<xref rid="cit0076" ref-type="bibr">76</xref>]. A distinguishing feature of IgA1 protease that it shares with three other zinc metalloproteases is that its LPXTG motif is present on the amino-terminus instead of the carboxyl-terminus [<xref rid="cit0075" ref-type="bibr">75</xref>,<xref rid="cit0076" ref-type="bibr">76</xref>]. IgA protease appears to be active in multiple forms with masses ranging from approximately 120 to 220 kilodaltons [<xref rid="cit0077" ref-type="bibr">77</xref>]. This protein can split and then recombine to form an active protease with the amino-terminal region binding IgA1 and the carboxyl-terminal region exhibiting protease activity [<xref rid="cit0078" ref-type="bibr">78</xref>].</p><p>IgA1 protease cuts the hinge region of the Fc fragment of human IgA1 [<xref rid="cit0079" ref-type="bibr">79</xref>] while leaving the Fab fragments attached to the bacteria [<xref rid="cit0080" ref-type="bibr">80</xref>]. The cleavage site in the hinge region of human IgA1 by streptococcal IgA1 proteases is at a proline-threonine bond [<xref rid="cit0079" ref-type="bibr">79</xref>], although <italic>S. pneumoniae</italic> IgA1 protease (unlike that from other streptococcal species) effectively cleaves at this location when these amino acids are substituted [<xref rid="cit0080" ref-type="bibr">80</xref>,<xref rid="cit0081" ref-type="bibr">81</xref>]. As a result of cleavage, the binding of the Fc portion of IgA1 to <italic>S. pneumoniae</italic> is reduced, and neutrophil phagocytosis of <italic>S. pneumoniae</italic> mediated by capsule-specific IgA1 is inhibited [<xref rid="cit0082" ref-type="bibr">82</xref>]. Moreover, Fab fragment decoration on the bacteria enhances their attachment to host epithelial cells via the receptor for platelet-activating factor (rPAF), promoting pathogenesis [<xref rid="cit0083" ref-type="bibr">83</xref>].</p><p>IgA1 protease is required for virulence in a mouse model of intranasal infection. Intranasal infection with an IgA1 protease-negative <italic>S. pneumoniae</italic> strain resulted in significantly increased mouse survival compared to infection with the parent strain [<xref rid="cit0084" ref-type="bibr">84</xref>]. As part of a protein vaccine, IgA1 protease provided protection against pneumococcal pneumonia in mice with decreased bacterial loads recovered from blood, lungs, and nares [<xref rid="cit0085" ref-type="bibr">85</xref>].</p></sec><sec id="s0012" disp-level="1"><title>Murein (Peptidoglycan) Peptidases DacA and DacB</title><p>Maintenance of bacterial cell shape and peptidoglycan turnover during division are important to the viability and fitness of <italic>S. pneumoniae</italic>, which in turn renders these activities important for virulence potential. Moreover, peptidoglycan is recognized by host receptors such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs) which mediate immune responses to pathogens. Bacterial carboxypeptidases function to cleave amino acids from the ends of the peptidoglycan stem pentapeptides, and endopeptidases cleave within peptides of the stems or the cross-bridges. D-alanyl-D-alanine carboxypeptidase (DacA; also known as penicillin-binding protein 3) is a bacterial cell wall-attached carboxypeptidase that has been extensively characterized [<xref rid="cit0086" ref-type="bibr">86&#x02013;88</xref>]. DacA cleaves the bond between the two D-alanine residues of the stem peptide, then a second carboxypeptidase, DacB (also known as LdcB for &#x0201c;L,D-carboxypeptidase B&#x0201d;), cleaves the next bond remaining (between L-lysine and D-alanine) [<xref rid="cit0089" ref-type="bibr">89</xref>]. Although protein sequence analysis indicates it to be a putative D,D-carboxypeptidase, DacB has instead been verified to be an L,D-carboxypeptidase [<xref rid="cit0086" ref-type="bibr">86</xref>,<xref rid="cit0089" ref-type="bibr">89&#x02013;91</xref>].</p><p>DacA and DacB were investigated for their possible roles in virulence in a mouse model of intranasal inoculation leading to pneumonia and sepsis [<xref rid="cit0086" ref-type="bibr">86</xref>]. Pneumococcal mutants with <italic>dacA</italic> deletion produced lung and blood infection similar to the parent strain, although onset of sepsis was slightly delayed. In contrast, mutants with <italic>dacB</italic> or <italic>dacA/dacB</italic> deletions were significantly attenuated in virulence, with marked delays in spread to lungs and subsequently the bloodstream [<xref rid="cit0086" ref-type="bibr">86</xref>].</p></sec><sec id="s0013" disp-level="1"><title>Neutral Endopeptidase O (PepO)</title><p>Neutral endopeptidase O (PepO) belongs to the M13 family of peptidases, a wide group of metallopeptidases in eukaryotes and bacteria, which possess cytoplasmic, transmembrane, and extracellular domains with the carboxyl-terminal extracellular domain containing the catalytic site [<xref rid="cit0061" ref-type="bibr">61</xref>]. In <italic>S. pneumoniae</italic>, PepO has been found to be released into the extracellular medium beginning in early logarithmic phase and its secretion increases as bacterial growth progresses [<xref rid="cit0092" ref-type="bibr">92</xref>]. PepO binds to and cleaves plasminogen to generate plasmin when in the presence of urokinase-type plasminogen activator (uPA), resulting in cleavage of complement component C3b [<xref rid="cit0092" ref-type="bibr">92</xref>]. Moreover, PepO reduces C3b deposition on <italic>S. pneumoniae</italic> [<xref rid="cit0092" ref-type="bibr">92</xref>,<xref rid="cit0093" ref-type="bibr">93</xref>]. PepO also binds to fibronectin, but the degree of binding appears to be strain-specific as one strain of <italic>S. pneumoniae</italic> deficient in PepO experienced a ~&#x000a0;75% loss of binding whereas another strain did not have significant loss of binding to fibronectin [<xref rid="cit0092" ref-type="bibr">92</xref>]. The ability of PepO to activate plasminogen in the presence of uPA resembles the binding of other <italic>S. pneumoniae</italic> proteins, most notably enolase, but also CbpA/PspC/SpsA and translation elongation factor Tu (Tuf), to plasminogen [<xref rid="cit0035" ref-type="bibr">35</xref>, <xref rid="cit0092" ref-type="bibr">92</xref>, <xref rid="cit0094" ref-type="bibr">94</xref> .</p><p>Exogenously added PepO reduces adhesion and invasion of lung cells by <italic>S. pneumoniae</italic>, suggesting that PepO is involved in attachment to host cells [<xref rid="cit0092" ref-type="bibr">92</xref>]. Complement component C1q enhances pneumococcal attachment to host cells, and PepO also binds to C1q; this binding can occur with secreted or cell surface-bound PepO [<xref rid="cit0093" ref-type="bibr">93</xref>]. Pre-treatment of serum with PepO inhibits the ability of aggregated immunoglobulin G (IgG) to activate the classical complement cascade at the C1q step, and PepO can activate complement to similar levels as those of IgG as determined by C1q and C3 deposition [<xref rid="cit0093" ref-type="bibr">93</xref>]. PepO also binds to the complement inhibitor C4b-binding protein (C4BP) and this interaction is noncompetitive with PepO binding to C1q. It has been proposed that secreted PepO, bound or not bound by C1q, binds and inactivates C4BP, leading to complement consumption as a result of unregulated activation. At the same time, surface-exposed (non-secreted) PepO bound by C1q promotes <italic>S. pneumoniae</italic> attachment to host epithelial cells. In this model, <italic>S. pneumoniae</italic> would evade complement deposition while exploiting complement components to colonize and invade host cells [<xref rid="cit0093" ref-type="bibr">93</xref>]. On the other hand, it has also been shown that PepO enhances phagocytosis by macrophages, indicating that PepO aids the host defense against <italic>S. pneumoniae</italic> [<xref rid="cit0095" ref-type="bibr">95</xref>,<xref rid="cit0096" ref-type="bibr">96</xref>].</p><p>PepO stimulates Toll-like receptors 2 and 4 (TLR2 and TLR4), which recognize bacterial patterns and trigger intracellular signaling cascades resulting in the production of inflammatory cytokines [<xref rid="cit0095" ref-type="bibr">95</xref>,<xref rid="cit0097" ref-type="bibr">97</xref>]. PepO increases the production of cytokines in mouse lungs, and this increase is abrogated in TLR4-negative mice with a lesser effect observed in TLR2-negative mice [<xref rid="cit0097" ref-type="bibr">97</xref>]. It has been proposed that exogenous PepO could be used as an immunotherapeutic to treat <italic>S. pneumoniae</italic> infections [<xref rid="cit0095" ref-type="bibr">95</xref>]. Whether PepO is a bona fide virulence factor [<xref rid="cit0092" ref-type="bibr">92</xref>,<xref rid="cit0093" ref-type="bibr">93</xref>] or not [<xref rid="cit0095" ref-type="bibr">95&#x02013;97</xref>] is not fully resolved.</p></sec><sec id="s0014" disp-level="1"><title>Pneumococcal Histidine Triad Protein A (PhtA; also PhpA)</title><p>Following the finding that <italic>S. pneumoniae</italic> produced C3-degrading activity [<xref rid="cit0053" ref-type="bibr">53</xref>], Hostetter identified two proteases that potentially comprise such activity [<xref rid="cit0098" ref-type="bibr">98</xref>]. One of these proteins was CppA (described above) and the other was a 20 kDa fragment of a larger 79 kDa protein. This protein was named pneumococcal histidine protein A, or PhpA [<xref rid="cit0099" ref-type="bibr">99</xref>], but is more commonly known as PhtA. PhtA is one of at least four known histidine triad proteins in <italic>S. pneumoniae</italic>, and these proteins have been shown to have high affinity for zinc. PhtA possesses a putative signal sequence, suggesting its localization to the cell surface [<xref rid="cit0100" ref-type="bibr">100</xref>].Deletion of PhtA and the other three Pht proteins results in increased C3 binding to <italic>S. pneumoniae</italic>; however, single deletion of PhtA has no effect on C3 deposition, suggesting that these proteins have interdependent roles regarding effect on complement [<xref rid="cit0101" ref-type="bibr">101</xref>,<xref rid="cit0102" ref-type="bibr">102</xref>]. Immunization of mice with PhtA significantly improved survival following intranasal infection [<xref rid="cit0099" ref-type="bibr">99</xref>], and intraperitoneal infection with serotypes 6A and 6B [<xref rid="cit0100" ref-type="bibr">100</xref>], of <italic>S. pneumoniae</italic>.</p></sec><sec id="s0015" disp-level="1"><title>Pneumococcal Protease A (PrtA)</title><p>PrtA is a cell wall-associated serine protease of the S8 family of peptidases, which cleave amino-terminal leader sequences from lantibiotics [<xref rid="cit0103" ref-type="bibr">103</xref>,<xref rid="cit0061" ref-type="bibr">61</xref>]. Lantibiotics are bacteriocin peptides that are cidal to competing bacteria. Systemic infection of mice with a <italic>prtA</italic> mutant strain of <italic>S. pneumoniae</italic> resulted in significantly longer survival times compared to infection with the parent strain [<xref rid="cit0103" ref-type="bibr">103</xref>]. The gene encoding PrtA is upregulated in blood following systemic infection in mice and a PrtA-deficient strain is significantly attenuated in an intranasal infection model. PrtA appeared to be required for movement to the mouse lung following intranasal infection, as the <italic>prtA</italic> mutant colonized the nasopharynx similar to its parent strain but had reduced colony-forming units in the lung [<xref rid="cit0104" ref-type="bibr">104</xref>]. This effect was found to be strain-specific as PrtA was not required for full virulence in all strain backgrounds tested [<xref rid="cit0060" ref-type="bibr">60</xref>,<xref rid="cit0104" ref-type="bibr">104</xref>]. Nonetheless, PrtA interacts with collagen type IV and plasminogen, suggesting that its possible cleavage of these substrates could contribute to tissue invasion and breach into the bloodstream [<xref rid="cit0105" ref-type="bibr">105</xref>]. In contrast, PrtA cleaves human apolactoferrin to generate lactoferricin-like peptide, which acts as a cationic antimicrobial peptide and kills <italic>S. pneumoniae</italic> [<xref rid="cit0106" ref-type="bibr">106</xref>]. The cleavage of apolactoferrin to promote killing of <italic>S. pneumoniae</italic> does not support the notion that PrtA is a virulence factor, although there may be another unidentified mechanism to promote virulence that would require this cleavage.</p></sec><sec id="s0016" disp-level="1"><title>Signal Peptidases</title><p>Signal peptidases are important for the processing and display, secretion, and/or function of proteins produced by bacteria. Type I signal peptidases are serine peptidases with catalytic dyads comprised of serine and lysine, that cleave amino-terminal leader peptides from many proteins and have been well-described for the canonical Sec machinery in bacterial secretion systems. Type II signal peptidases are aspartate peptidases that recognize a lipobox sequence of four amino acids in pro-lipoproteins, cleaving the lipoproteins to their mature forms.</p><p>Signal peptidase I (leader peptidase LepB) in <italic>S. pneumoniae</italic>, a single-pass transmembrane protein with an extracellularly exposed carboxyl-terminus [<xref rid="cit0061" ref-type="bibr">61</xref>], is required for bacterial viability [<xref rid="cit0107" ref-type="bibr">107</xref>]. Lipoprotein signal peptidase (LspA) is a transmembrane type II signal peptidase which cleaves amino-terminal signal peptides containing lipobox sequences with a conserved cysteine from pro-lipoproteins [<xref rid="cit0108" ref-type="bibr">108</xref>]. Lipoproteins are anchored to the exterior of the pneumococcal cell membrane following modification by a lipoprotein diacylglyceryl transferase, Lgt, then they are cleaved by LspA. Proteomic analysis of the <italic>S. pneumoniae</italic> surface and extracellular contents showed that Lsp is necessary for the maintenance of cell surface localization for some proteins and for overall protein integrity for others [<xref rid="cit0109" ref-type="bibr">109</xref>]. Interestingly, in the absence of Lgt, LspA was shown to process specific proteins despite the lack of post-translational modification by Lgt. Furthermore, the lipoprotein SlrA was cleaved of its signal peptide in the absence of both Lgt and LspA, indicating that <italic>S. pneumoniae</italic> may possess an alternate lipopeptidase [<xref rid="cit0109" ref-type="bibr">109</xref>].</p><p>Lipoproteins comprise subunits of ABC transporters in <italic>S. pneumoniae</italic> which serve a variety of functions. For example, a manganese uptake ABC transporter lipoprotein helps protect <italic>S. pneumoniae</italic> from oxidative stress. Deletion of the gene encoding LspA causes a failure in cleavage of the pro-lipoprotein of this ABC transporter and impaired protection from oxidative stress. Loss of LspA results in reduced virulence in mouse pneumonia and septicemia models of infection [<xref rid="cit0108" ref-type="bibr">108</xref>].</p></sec><sec id="s0017" disp-level="1"><title>Zinc Metalloprotease B (ZmpB)</title><p>The gene encoding ZmpB is present in all strains of <italic>S. pneumoniae</italic> tested [<xref rid="cit0110" ref-type="bibr">110</xref>]. ZmpB contains an amino-terminal LPXTG motif and is tethered to the cell surface with the carboxyl end exposed. Two studies of ZmpB function related to bacterial physiology yielded conflicting data. One study reported that <italic>zmpB</italic> mutants of an encapsulated type 4 strain were unable to autolyze, formed long chains, lacked surface expression of specific choline-binding proteins comcomitant with intracellular entrapment of autolysin (LytA) and CbpA/PspC/SpsA, and were reduced in transformation efficiency [<xref rid="cit0111" ref-type="bibr">111</xref>]. In contrast, another group reported that none of these effects occurred in their <italic>zmpB</italic> mutants in a non-encapsulated strain, which was then tested and confirmed in a type 4 strain [<xref rid="cit0028" ref-type="bibr">28</xref>]. The latter group ascertained that the <italic>zmpB</italic> mutant strain used in the first study was actually a Viridans group streptococcus and was not derived from the parent <italic>S. pneumoniae</italic> strain [<xref rid="cit0028" ref-type="bibr">28</xref>].</p><p>ZmpB is required for virulence in mouse models of pneumococcal pneumonia and septicemia. Mucosal immunization with ZmpB was protective against pneumonia and septicemia potentially via T helper 1 (Th1) and Th17 responses [<xref rid="cit0112" ref-type="bibr">112</xref>]. Additionally, mice infected with <italic>zmpB</italic> knockout strains had significantly increased survival compared to those infected with the parent strains [<xref rid="cit0084" ref-type="bibr">84</xref>,<xref rid="cit0113" ref-type="bibr">113</xref>]. Bacterial quantities in the blood were significantly reduced following infection with a <italic>zmpB</italic> mutant, and the lack of an effect in complement C3-negative mice indicated that ZmpB does not affect complement-mediated opsonization. Reduced levels of tumor necrosis factor-alpha (TNF-alpha) in the lungs suggested that ZmpB could be required for inflammatory events leading to <italic>S. pneumoniae</italic> translocation from the lungs to the blood [<xref rid="cit0113" ref-type="bibr">113</xref>]. Since ZmpB interacts with collagen type IV, likely through proteolytic cleavage, perhaps ZmpB compromises the integrity of lung cell collagen type IV to invade the blood [<xref rid="cit0105" ref-type="bibr">105</xref>].</p><p>Despite its interaction with collagen type IV, ZmpB was not required for intranasal colonization or bacterial survival in lungs, suggesting that this protease is not required for bacterial adhesion to host cells [<xref rid="cit0113" ref-type="bibr">113</xref>]. However, competitive inhibition by recombinant ZmpB or ZmpB antibodies reduces bacterial binding to lung cells <italic>in vitro</italic> [<xref rid="cit0112" ref-type="bibr">112</xref>]. The strain background and presence or absence of other zinc metalloproteases with possible functional redundancy could be contributing factors, as well as the sequence variations between <italic>zmpB</italic> genes among different strains of <italic>S. pneumoniae</italic> [<xref rid="cit0114" ref-type="bibr">114</xref>].</p></sec><sec id="s0018" disp-level="1"><title>Zinc Metalloprotease C (ZmpC)</title><p>The gene encoding ZmpC is present in only about 18&#x02013;24% of <italic>S. pneumoniae</italic> clinical strains [<xref rid="cit0110" ref-type="bibr">110</xref>,<xref rid="cit0115" ref-type="bibr">115</xref>,<xref rid="cit0116" ref-type="bibr">116</xref>]. As for ZmpB, ZmpC is sorted to the cell surface via an amino-terminal LPXTG. Strains that harbor <italic>zmpC</italic> are associated with more severe clinical disease [<xref rid="cit0115" ref-type="bibr">115</xref>], and ZmpC has been shown to be required for virulence in a mouse model of pneumonia [<xref rid="cit0117" ref-type="bibr">117</xref>]. In contrast, ZmpC-negative <italic>S. pneumoniae</italic> cause increased mortality and increased bacterial loads in the blood and brains of mice infected via the intravenous route, which was suggested to be a strategy by ZmpC-positive <italic>S. pneumoniae</italic> to extend the life of the host to benefit bacterial survival [<xref rid="cit0118" ref-type="bibr">118</xref>]. ZmpC causes ectodomain shedding of syndecan-1, a heparin sulfate proteoglycan present on epithelial cells, from mouse mammary gland epithelial cells [<xref rid="cit0119" ref-type="bibr">119</xref>]. This shedding event is significantly reduced by inhibitors of metalloproteinase activity, Ilomastat and TNF-alpha protease inhibitor 1 (TAPI-1), indicating that the protease activity of ZmpC is responsible for ectodomain shedding [<xref rid="cit0119" ref-type="bibr">119</xref>]. Direct cleavage of syndecan-1 ectodomains by semi-purified native ZmpC was also demonstrated, confirming the protease activity [<xref rid="cit0119" ref-type="bibr">119</xref>]. Furthermore, ZmpC causes ectodomain shedding of membrane-associated mucin MUC16 from human tracheobronchial, corneal, and conjunctival cells [<xref rid="cit0120" ref-type="bibr">120</xref>]. ZmpC also cleaves and activates human matrix metalloproteinase 9 (MMP-9) [<xref rid="cit0117" ref-type="bibr">117</xref>]. Collectively these results show that ZmpC is a virulence factor with several host substrate targets that are important for structural integrity, mucosal protection, and tissue remodeling.</p><p>Another host target of ZmpC is the neutrophil. ZmpC cuts P-Selectin Glycoprotein-1 (PSGL-1) present on human neutrophils, inhibiting its ability to bind to P-Selectin on endothelial cells [<xref rid="cit0116" ref-type="bibr">116</xref>]. By reducing the neutrophil&#x02019;s ability to bind to endothelial cells, initial neutrophil rolling movement along the blood vessel lumen is interrupted and thus extravasation is inhibited. Subverting neutrophil extravasation, therefore, would also cause a decrease in phagocytic clearance of <italic>S. pneumoniae</italic>. Indeed, neutrophil rolling was inhibited by ZmpC <italic>in vitro</italic>, and reduced neutrophils were recovered from mouse lung lumen while neutrophil numbers were unaffected in the lung interstitial tissue <italic>in vivo</italic> during the early stage of infection by a <italic>zmpC</italic> mutant of <italic>S. pneumoniae</italic> [<xref rid="cit0116" ref-type="bibr">116</xref>].</p></sec><sec id="s0019" disp-level="1"><title>Zinc Metalloprotease D (ZmpD)</title><p>The presence of ZmpD in <italic>S. pneumoniae</italic> strains is variable, with about half of strains possessing <italic>zmpD</italic> in the chromosome [<xref rid="cit0110" ref-type="bibr">110</xref>]. The gene encoding ZmpD appears to be acquired from genetic recombination events between members of the Mitis group of streptococci [<xref rid="cit0027" ref-type="bibr">27</xref>]. When present, <italic>zmpD</italic> is located adjacent to the gene which encodes IgA1 protease (<italic>zmpA</italic>, or <italic>iga</italic>) and its presence is hypothesized to be a result of a duplication event [<xref rid="cit0027" ref-type="bibr">27</xref>]. The <italic>zmpA/zmpD, zmpB</italic>, and <italic>zmpC</italic> loci are distinct from each other and exhibit high sequence variability in <italic>S. pneumoniae</italic> [<xref rid="cit0027" ref-type="bibr">27</xref>]. ZmpD shares a similar cellular locale as the other zinc metalloproteases in that this enzyme has an amino-terminal LPXTG motif and is attached to the surface of <italic>S. pneumoniae</italic>. The specific functional role of ZmpD in pathogenesis is unknown.</p></sec></body><back><sec id="s0020" disp-level="1"><title>Summary: Putting the Pieces Together</title><p>In terms of pathogenesis, <italic>S. pneumoniae</italic> colonizes the nasopharynx and then spreads to other sites depending on a variety of bacterial and host factors. Pneumococcal proteases with confirmed or tentative functions in colonization (including transmission) are shown in <xref ref-type="fig" rid="f0001">Figure 1</xref>. It is not surprising to find that surface choline-binding proteins would be involved in colonization, as these types of proteins have been shown to be important for adherence to host cells. ClpP and HtrA, however, are proteases with classical protein processing or chaperone functions for other pneumococcal proteins. Do these proteases directly cleave host proteins, or do they possess more complex post-translational regulatory functions involving other pneumococcal factors?<fig id="f0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Pneumococcal proteases implicated in A) colonization, B) pneumonia, and C) septicemia</p></caption><alternatives><graphic specific-use="web-only" content-type="color" xlink:href="KVIR_A_1889812_F0001_OC"/><graphic specific-use="print-only" content-type="black-white" xlink:href="KVIR_A_1889812_F0001_PB"/></alternatives></fig></p><p>Following colonization, the two pneumococcal diseases that are best represented in protease function studies to date are pneumonia and septicemia (<xref ref-type="fig" rid="f0001">Figure 1</xref>). ClpP is implicated for both of these diseases, and HtrA is implicated in pneumonia; the question of direct impact on host proteins or indirect effects of these proteases remains. IgA1 protease and ZmpB, however, have less nebulous roles. IgA1 protease directly cleaves human IgA1, which is present at mucosal sites such as lung epithelium, leaving the Fc portions of IgA1 molecules cut and removed from the Fab fragments that bind the pneumococci. ZmpB cleaves collagen, an important lung tissue component, and this function has been suggested to contribute to its role in blood infection by the breach of barriers resulting from collagen cleavage. An interesting item of note is that CbpG has thus far been determined to be necessary for colonization as well as septicemia, perhaps due in part to its fibronectin-cleaving ability. CbpG, unlike ClpP which has also been reported to play roles in both colonization and invasive disease, is not ascribed the function of a processor of bacterial proteins. A protease such as ClpP might be expected to be involved at all stages of colonization and infection by nature of its regulatory function for the bacteria; however, a protease such as CbpG might be a different type of moonlighting protein with multiple functions, or alternately expressed depending on niche conditions. Indeed, at the cellular level, the choline-binding domain of CbpG contributes to pneumococcal attachment to epithelial cells (<xref ref-type="fig" rid="f0002">Figure 2</xref>). IgA1 protease cleavage of IgA1 also contributes to host cell binding, as pneumococci with bound Fab fragments attach at epithelial rPAF.<fig id="f0002" fig-type="figure" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Roles of pneumococcal proteases at the host cellular level. (a) At least 5 proteases are involved in attachment to nasopharyngeal or lung epithelial cells. (b) Pneumococcal proteases can inhibit complement deposition, as depicted by the abridged classical complement pathway. CppA and histidine triad proteins degrade complement component C3, which is important for pathogen recognition by phagocytes. PepO can bind to C1q, but can also act as a complement activator and promote premature consumption by inhibiting the regulatory inhibitor C4BP. In the presence of uPA, PepO cleaves plasminogen to the proteolytically active plasmin, and plasmin prematurely degrades C3b and inhibits its deposition on <italic>S. pneumoniae</italic>. Since C3b is necessary for binding to complement receptor on phagocytes such as neutrophils (opsonization), inhibition of C3b deposition contributes to immune evasion</p></caption><alternatives><graphic specific-use="web-only" content-type="color" xlink:href="KVIR_A_1889812_F0002_OC"/><graphic specific-use="print-only" content-type="black-white" xlink:href="KVIR_A_1889812_F0002_PB"/></alternatives></fig></p><p>Aside from interactions at the host cell membrane, other molecular events that impact pneumococcal pathogenesis are the complement pathways [<xref rid="cit0121" ref-type="bibr">121</xref>]. One of the main outcomes of classical complement activation is the opsonization and phagocytosis of bacteria by host immune cells, and this outcome depends on the successful deposition of complement component C3b on the bacteria. Proteases that thwart this deposition are CppA, PepO, and PhtA in combination with the other Pht proteins (<xref ref-type="fig" rid="f0002">Figure 2</xref>).</p><p>Pneumococcal proteases are prime examples of the interconnectivity of bacterial biochemistry and pathogenesis. Most of the proteases and peptidases discussed herein serve essential functions in the maintenance of cellular functions through the cleavage of proteins as normal cellular processes, in response to environmental stressors such as a specific host niche, or as intra- and inter-species competition. The known and potential detrimental effects of these proteases on the host are increasingly becoming elucidated, in great part attributable to data mining of sequence information and proteomics tools.</p></sec><sec id="s0021" disp-level="1"><title>Data sharing</title><p>Data sharing is not applicable to this article as no new data were created or analyzed in this study.</p></sec><sec id="s0022" disp-level="1"><p>The author reports no conflict of interest.</p></sec><sec id="s0023" disp-level="1" sec-type="COI-statement"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the author.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anderton</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Rajam</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Romero-Steiner</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of <italic>Streptococcus pneumoniae</italic></article-title>. <source>Microb Pathog</source>. <year>2007</year>;<volume>42</volume>(<issue>5&#x02013;6</issue>):<fpage>225</fpage>&#x02013;<lpage>236</lpage>.<pub-id pub-id-type="pmid">17412553</pub-id></mixed-citation></ref><ref id="cit0002"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rosenow</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ryan</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Weiser</surname>
<given-names>JN</given-names></string-name>, et al</person-group>. <article-title>Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of <italic>Streptococcus pneumoniae</italic></article-title>. <source>Mol Microbiol</source>. <year>1997</year>;<volume>25</volume>(<issue>5</issue>):<fpage>819</fpage>&#x02013;<lpage>829</lpage>.<pub-id pub-id-type="pmid">9364908</pub-id></mixed-citation></ref><ref id="cit0003"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Voss</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hallstr&#x000f6;m</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Saleh</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>The choline-binding protein PspC of <italic>Streptococcus pneumoniae</italic> interacts with the C-terminal heparin-binding domain of vitronectin</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>22</issue>):<fpage>15614</fpage>&#x02013;<lpage>15627</lpage>.<pub-id pub-id-type="pmid">23603906</pub-id></mixed-citation></ref><ref id="cit0004"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Mostov</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Lamm</surname>
<given-names>ME</given-names></string-name>, et al</person-group>. <article-title>The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells</article-title>. <source>Cell</source>. <year>2000</year>;<volume>102</volume>(<issue>6</issue>):<fpage>827</fpage>&#x02013;<lpage>837</lpage>.<pub-id pub-id-type="pmid">11030626</pub-id></mixed-citation></ref><ref id="cit0005"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>King</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Hippe</surname>
<given-names>KR</given-names></string-name>, <string-name><surname>Weiser</surname>
<given-names>JN.</given-names></string-name></person-group>
<article-title>Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by <italic>Streptococcus pneumoniae</italic></article-title>. <source>Mol Microbiol</source>. <year>2006</year>;<volume>59</volume>(<issue>3</issue>):<fpage>961</fpage>&#x02013;<lpage>974</lpage>.<pub-id pub-id-type="pmid">16420364</pub-id></mixed-citation></ref><ref id="cit0006"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tong</surname>
<given-names>HH</given-names></string-name>, <string-name><surname>McIver</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Fisher</surname>
<given-names>LM</given-names></string-name>, et al</person-group>. <article-title>Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of<italic>Streptococcus pneumoniae</italic>to chinchilla tracheal epithelium</article-title>. <source>Microbial Pathogen</source>. <year>1999</year>;<volume>26</volume>(<issue>2</issue>):<fpage>111</fpage>&#x02013;<lpage>119</lpage>.</mixed-citation></ref><ref id="cit0007"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feldman</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Munro</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Jeffery</surname>
<given-names>PK</given-names></string-name>, et al</person-group>. <article-title>Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo</article-title>. <source>Am J Respir Cell Mol Biol</source>. <year>1991</year>;<volume>5</volume>(<issue>5</issue>):<fpage>416</fpage>&#x02013;<lpage>423</lpage>.<pub-id pub-id-type="pmid">1834101</pub-id></mixed-citation></ref><ref id="cit0008"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Houldsworth</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Andrew</surname>
<given-names>PW</given-names></string-name>, <string-name><surname>Mitchell</surname>
<given-names>TJ</given-names></string-name></person-group>. <article-title>Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes</article-title>. <source>Infect Immun</source>. <year>1994</year>;<volume>62</volume>(<issue>4</issue>):<fpage>1501</fpage>&#x02013;<lpage>1503</lpage>.<pub-id pub-id-type="pmid">8132361</pub-id></mixed-citation></ref><ref id="cit0009"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Subramanian</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Neill</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Malak</surname>
<given-names>H</given-names></string-name>, et al</person-group>. <article-title>Pneumolysin binds to the mannose-receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival</article-title>. <source>Nat Microbiol</source>. <year>2019</year>;<volume>4</volume>(<issue>1</issue>):<fpage>62</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">30420782</pub-id></mixed-citation></ref><ref id="cit0010"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ren</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Szalai</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>O</given-names></string-name>, et al</person-group>. <article-title>Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of <italic>Streptococcus pneumoniae</italic></article-title>. <source>Infect Immun</source>. <year>2003</year>;<volume>71</volume>(<issue>1</issue>):<fpage>75</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">12496151</pub-id></mixed-citation></ref><ref id="cit0011"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brown</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Joiner</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Cole</surname>
<given-names>RM</given-names></string-name>, et al</person-group>. <article-title>Localization of complement component 3 on <italic>Streptococcus pneumoniae</italic>: anti-capsular antibody causes complement deposition on the pneumococcal capsule.</article-title>. <source>Infect Immun</source>. <year>1983</year>;<volume>39</volume>(<issue>1</issue>):<fpage>403</fpage>&#x02013;<lpage>409</lpage>.<pub-id pub-id-type="pmid">6822421</pub-id></mixed-citation></ref><ref id="cit0012"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wood</surname>
<given-names>WB</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>MR</given-names></string-name></person-group>. <article-title>The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III</article-title>. <source>J Exp Med</source>. <year>1949</year>;<volume>90</volume>(<issue>1</issue>):<fpage>85</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">18152341</pub-id></mixed-citation></ref><ref id="cit0013"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wartha</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Beiter</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Albiger</surname>
<given-names>B</given-names></string-name>, et al</person-group>. <article-title>Capsule and d-alanylated lipoteichoic acids protect <italic>Streptococcus pneumoniae</italic> against neutrophil extracellular traps</article-title>. <source>Cell Microbiol</source>. <year>2007</year>;<volume>9</volume>(<issue>5</issue>):<fpage>1162</fpage>&#x02013;<lpage>1171</lpage>.<pub-id pub-id-type="pmid">17217430</pub-id></mixed-citation></ref><ref id="cit0014"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thibodeaux</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Caballero</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Marquart</surname>
<given-names>ME</given-names></string-name>, et al</person-group>. <article-title>Corneal virulence of <italic>Pseudomonas aeruginosa</italic> elastase B and alkaline protease produced by <italic>Pseudomonas putida</italic></article-title>. <source>Curr Eye Res</source>. <year>2007</year>;<volume>32</volume>(<issue>4</issue>):<fpage>373</fpage>&#x02013;<lpage>386</lpage>.<pub-id pub-id-type="pmid">17453960</pub-id></mixed-citation></ref><ref id="cit0015"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Le Berre</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Nowak</surname>
<given-names>E</given-names></string-name>, et al</person-group>. <article-title>Relative contribution of three main virulence factors in <italic>Pseudomonas aeruginosa</italic> pneumonia</article-title>. <source>Crit Care Med</source>. <year>2011</year>;<volume>39</volume>(<issue>9</issue>):<fpage>2113</fpage>&#x02013;<lpage>2120</lpage>.<pub-id pub-id-type="pmid">21572326</pub-id></mixed-citation></ref><ref id="cit0016"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maestro</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Sanz</surname>
<given-names>JM</given-names></string-name></person-group>. <article-title>Choline binding proteins from <italic>Streptococcus pneumoniae</italic>: a dual role as enzybiotics and targets for the design of new antimicrobials</article-title>. <source>Antibiotics (Basel)</source>. <year>2016</year>;<volume>5</volume>(<issue>2</issue>):<fpage>21</fpage>.</mixed-citation></ref><ref id="cit0017"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnson</surname>
<given-names>MK</given-names></string-name></person-group>. <article-title>Characterization of a peptidase from <italic>Diplococcus pneumoniae</italic></article-title>. <source>Antonie Van Leeuwenhoek</source>. <year>1973</year>;<volume>39</volume>(<issue>1</issue>):<fpage>599</fpage>&#x02013;<lpage>608</lpage>.<pub-id pub-id-type="pmid">4148977</pub-id></mixed-citation></ref><ref id="cit0018"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnson</surname>
<given-names>MK</given-names></string-name></person-group>. <article-title>Physiological roles of pneumococcal peptidases</article-title>. <source>J Bacteriol</source>. <year>1974</year>;<volume>119</volume>(<issue>3</issue>):<fpage>844</fpage>&#x02013;<lpage>847</lpage>.<pub-id pub-id-type="pmid">4212242</pub-id></mixed-citation></ref><ref id="cit0019"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kilian</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mestecky</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Schrohenloher</surname>
<given-names>RE</given-names></string-name></person-group>. <article-title>Pathogenic species of the genus <italic>Haemophilus</italic> and <italic>Streptococcus pneumoniae</italic> produce immunoglobulin A1 protease</article-title>. <source>Infect Immun</source>. <year>1979</year>;<volume>26</volume>(<issue>1</issue>):<fpage>143</fpage>&#x02013;<lpage>149</lpage>.<pub-id pub-id-type="pmid">40878</pub-id></mixed-citation></ref><ref id="cit0020"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Male</surname>
<given-names>CJ</given-names></string-name></person-group>. <article-title>Immunoglobulin A1 protease production by <italic>Haemophilus influenzae</italic> and <italic>Streptococcus pneumoniae</italic>.</article-title>
<source>Infect Immun</source>. 1979;<volume>156</volume>(<issue>1</issue>):<fpage>254</fpage>&#x02013;<lpage>261</lpage>.</mixed-citation></ref><ref id="cit0021"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Courtney</surname>
<given-names>HS</given-names></string-name></person-group>. <article-title>Degradation of connective tissue proteins by serine proteases from <italic>Streptococcus pneumoniae</italic></article-title>. <source>Biochem Biophys Res Commun</source>. <year>1991</year>;<volume>175</volume>(<issue>3</issue>):<fpage>1023</fpage>&#x02013;<lpage>1028</lpage>.<pub-id pub-id-type="pmid">1850992</pub-id></mixed-citation></ref><ref id="cit0022"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kwon</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hasseman</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Latham</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>Recombinant expression and functional analysis of proteases from <italic>Streptococcus pneumoniae, Bacillus anthracis</italic>, and <italic>Yersinia pestis</italic></article-title>. <source>BMC Biochem</source>. <year>2011</year>;<volume>12</volume>(<issue>1</issue>):<fpage>17</fpage>.<pub-id pub-id-type="pmid">21545736</pub-id></mixed-citation></ref><ref id="cit0023"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nganje</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Haynes</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Qabar</surname>
<given-names>CM</given-names></string-name>, et al</person-group>. <article-title>PepN is a non-essential, cell wall-localized protein that contributes to neutrophil elastase-mediated killing of <italic>Streptococcus pneumoniae</italic></article-title>. <source>PLoS One</source>. <year>2019</year>;<volume>14</volume>(<issue>2</issue>):<fpage>e0211632</fpage>.<pub-id pub-id-type="pmid">30707714</pub-id></mixed-citation></ref><ref id="cit0024"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blevins</surname>
<given-names>LK</given-names></string-name>, <string-name><surname>Parsonage</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Oliver</surname>
<given-names>MB</given-names></string-name>, et al</person-group>. <article-title>A novel function for the <italic>Streptococcus pneumoniae</italic> aminopeptidase N: inhibition of T cell effector function through the regulation of TCR signaling</article-title>. <source>Front Immunol</source>. <year>2017</year>;<volume>8</volume>:<fpage>1610</fpage>.<pub-id pub-id-type="pmid">29230212</pub-id></mixed-citation></ref><ref id="cit0025"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>G</given-names></string-name>, et al</person-group>. <article-title><italic>Streptococcus pneumoniae</italic> aminopeptidase N contributes to bacterial virulence and elicits a strong innate immune response through MAPK and PI3K/AKT signaling</article-title>. <source>J Microbiol</source>. <year>2020</year>;<volume>58</volume>(<issue>4</issue>):<fpage>330</fpage>&#x02013;<lpage>339</lpage>.<pub-id pub-id-type="pmid">32103444</pub-id></mixed-citation></ref><ref id="cit0026"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pei</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mitchell</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Dixon</surname>
<given-names>JE</given-names></string-name>, et al</person-group>. <article-title>Expansion of type II CAAX proteases reveals evolutionary origin of gamma-secretase subunit APH-1</article-title>. <source>J Mol Biol</source>. <year>2011</year>;<volume>410</volume>(<issue>1</issue>):<fpage>18</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">21570408</pub-id></mixed-citation></ref><ref id="cit0027"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bek-Thomsen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Poulsen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Kilian</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Occurrence and evolution of the paralogous zinc metalloproteases IgA1 protease, ZmpB, ZmpC, and ZmpD in <italic>Streptococcus pneumoniae</italic> and related commensal species</article-title>. <source>mBio</source>. <year>2012</year>;<volume>3</volume>(<issue>5</issue>):<fpage>e00303</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="cit0028"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berg&#x000e9;</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Garc&#x000ed;a</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Iannelli</surname>
<given-names>F</given-names></string-name>, et al</person-group>. <article-title>The puzzle of zmpB and extensive chain formation, autolysis defect and non-translocation of choline-binding proteins in <italic>Streptococcus pneumoniae</italic></article-title>. <source>Mol Microbiol</source>. <year>2001</year>;<volume>39</volume>(<issue>6</issue>):<fpage>1651</fpage>&#x02013;<lpage>1660</lpage>.<pub-id pub-id-type="pmid">11260480</pub-id></mixed-citation></ref><ref id="cit0029"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>L&#x000f6;fling</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Vimberg</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Battig</surname>
<given-names>P</given-names></string-name>, et al</person-group>. <article-title>Cellular interactions by LPxTG-anchored pneumococcal adhesins and their streptococcal homologues</article-title>. <source>Cell Microbiol</source>. <year>2011</year>;<volume>13</volume>(<issue>2</issue>):<fpage>186</fpage>&#x02013;<lpage>197</lpage>.<pub-id pub-id-type="pmid">21199258</pub-id></mixed-citation></ref><ref id="cit0030"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>H&#x000e5;varstein</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Coomaraswamy</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Morrison</surname>
<given-names>DA</given-names></string-name></person-group>. <article-title>An unmodified heptadecapeptide pheromone induces competence for genetic transformation in <italic>Streptococcus pneumoniae</italic>.</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1995</year>;<volume>92</volume>(<issue>24</issue>):<fpage>11140</fpage>&#x02013;<lpage>11144</lpage>.<pub-id pub-id-type="pmid">7479953</pub-id></mixed-citation></ref><ref id="cit0031"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>H&#x000e5;varstein</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Johnsborg</surname>
<given-names>O</given-names></string-name>, et al</person-group>. <article-title>New insights into the pneumococcal fratricide: relationship to clumping and identification of a novel immunity factor</article-title>. <source>Mol Microbiol</source>. <year>2006</year>;<volume>59</volume>(<issue>4</issue>):<fpage>1297</fpage>&#x02013;<lpage>1307</lpage>.<pub-id pub-id-type="pmid">16430701</pub-id></mixed-citation></ref><ref id="cit0032"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gosink</surname>
<given-names>KK</given-names></string-name>, <string-name><surname>Mann</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Guglielmo</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>Role of novel choline binding proteins in virulence of <italic>Streptococcus pneumoniae</italic></article-title>. <source>Infect Immun</source>. <year>2000</year>;<volume>68</volume>(<issue>10</issue>):<fpage>5690</fpage>&#x02013;<lpage>5695</lpage>.<pub-id pub-id-type="pmid">10992472</pub-id></mixed-citation></ref><ref id="cit0033"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Straume</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Stams&#x000e5;s</surname>
<given-names>GA</given-names></string-name>, <string-name><surname>Salehian</surname>
<given-names>Z</given-names></string-name>, et al</person-group>. <article-title>Overexpression of the fratricide immunity protein ComM leads to growth inhibition and morphological abnormalities in <italic>Streptococcus pneumoniae</italic></article-title>. <source>Microbiology</source>. <year>2017</year>;<volume>163</volume>(<issue>1</issue>):<fpage>9</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">27902435</pub-id></mixed-citation></ref><ref id="cit0034"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mann</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Orihuela</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Antikainen</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Multifunctional role of choline binding protein G in pneumococcal pathogenesis</article-title>. <source>Infect Immun</source>. <year>2006</year>;<volume>74</volume>(<issue>2</issue>):<fpage>821</fpage>&#x02013;<lpage>829</lpage>.<pub-id pub-id-type="pmid">16428724</pub-id></mixed-citation></ref><ref id="cit0035"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meinel</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Spart&#x000e0;</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Dahse</surname>
<given-names>H-M</given-names></string-name>, et al</person-group>. <article-title><italic>Streptococcus pneumoniae</italic> from patients with hemolytic uremic syndrome binds human plasminogen via the surface protein PspC and uses plasmin to damage human endothelial cells</article-title>. <source>J Infect Dis</source>. <year>2018</year>;<volume>217</volume>(<issue>3</issue>):<fpage>358</fpage>&#x02013;<lpage>370</lpage>.<pub-id pub-id-type="pmid">28968817</pub-id></mixed-citation></ref><ref id="cit0036"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>D</given-names></string-name>, et al</person-group>. <article-title>CD4+ T lymphocytes mediated protection against invasive pneumococcal infection induced by mucosal immunization with ClpP and CbpA</article-title>. <source>Vaccine</source>. <year>2009</year>;<volume>27</volume>(<issue>21</issue>):<fpage>2838</fpage>&#x02013;<lpage>2844</lpage>.<pub-id pub-id-type="pmid">19366577</pub-id></mixed-citation></ref><ref id="cit0037"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>Pneumococcal ClpP modulates the maturation and activation of human dendritic cells: implications for pneumococcal infections</article-title>. <source>J Leukoc Biol</source>. <year>2013</year>;<volume>93</volume>(<issue>5</issue>):<fpage>737</fpage>&#x02013;<lpage>749</lpage>.<pub-id pub-id-type="pmid">23381472</pub-id></mixed-citation></ref><ref id="cit0038"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Park</surname>
<given-names>C-Y</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>E-H</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>S-Y</given-names></string-name>, et al</person-group>. <article-title>Virulence attenuation of <italic>Streptococcus pneumoniae clpP</italic> mutant by sensitivity to oxidative stress in macrophages via an NO-mediated pathway</article-title>. <source>J Microbiol</source>. <year>2010</year>;<volume>48</volume>(<issue>2</issue>):<fpage>229</fpage>&#x02013;<lpage>235</lpage>.<pub-id pub-id-type="pmid">20437156</pub-id></mixed-citation></ref><ref id="cit0039"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Gong</surname>
<given-names>Y</given-names></string-name>, et al</person-group>. <article-title>Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection</article-title>. <source>Clin Exp Immunol</source>. <year>2009</year>;<volume>156</volume>(<issue>1</issue>):<fpage>52</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">19220325</pub-id></mixed-citation></ref><ref id="cit0040"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pestova</surname>
<given-names>EV</given-names></string-name>, <string-name><surname>H&#x000e5;varstein</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Morrison</surname>
<given-names>DA</given-names></string-name></person-group>. <article-title>Regulation of competence for genetic transformation in <italic>Streptococcus pneumoniae</italic> by an auto-induced peptide pheromone and a two-component regulatory system</article-title>. <source>Mol Microbiol</source>. <year>1996</year>;<volume>21</volume>(<issue>4</issue>):<fpage>853</fpage>&#x02013;<lpage>862</lpage>.<pub-id pub-id-type="pmid">8878046</pub-id></mixed-citation></ref><ref id="cit0041"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chastanet</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Prudhomme</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Claverys</surname>
<given-names>JP</given-names></string-name>, et al</person-group>. <article-title>Regulation of <italic>Streptococcus pneumoniae clp</italic> genes and their role in competence development and stress survival</article-title>. <source>J Bacteriol</source>. <year>2001</year>;<volume>183</volume>(<issue>24</issue>):<fpage>7295</fpage>&#x02013;<lpage>7307</lpage>.<pub-id pub-id-type="pmid">11717289</pub-id></mixed-citation></ref><ref id="cit0042"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Robertson</surname>
<given-names>GT</given-names></string-name>, <string-name><surname>Ng</surname>
<given-names>WL</given-names></string-name>, <string-name><surname>Foley</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Global transcriptional analysis of clpP mutations of type 2 <italic>Streptococcus pneumoniae</italic> and their effects on physiology and virulence</article-title>. <source>J Bacteriol</source>. <year>2002</year>;<volume>184</volume>(<issue>13</issue>):<fpage>3508</fpage>&#x02013;<lpage>3520</lpage>.<pub-id pub-id-type="pmid">12057945</pub-id></mixed-citation></ref><ref id="cit0043"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Gallay</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kjos</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>High-throughput CRISPRi phenotyping identifies new essential genes in <italic>Streptococcus pneumoniae</italic></article-title>. <source>Mol Syst Biol</source>. <year>2017</year>;<volume>13</volume>(<issue>5</issue>):<fpage>931</fpage>.<pub-id pub-id-type="pmid">28490437</pub-id></mixed-citation></ref><ref id="cit0044"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Turgay</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hahn</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Burghoorn</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Competence in <italic>Bacillus subtilis</italic> is controlled by regulated proteolysis of a transcription factor</article-title>. <source>Embo J</source>. <year>1998</year>;<volume>17</volume>:<fpage>6730</fpage>&#x02013;<lpage>6738</lpage>.<pub-id pub-id-type="pmid">9890793</pub-id></mixed-citation></ref><ref id="cit0045"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sung</surname>
<given-names>CK</given-names></string-name>, <string-name><surname>Morrison</surname>
<given-names>DA</given-names></string-name></person-group>. <article-title>Two distinct functions of ComW in stabilization and activation of the alternative sigma factor ComX in <italic>Streptococcus pneumoniae</italic></article-title>. <source>J Bacteriol</source>. <year>2005</year>;<volume>187</volume>(<issue>9</issue>):<fpage>3052</fpage>&#x02013;<lpage>3061</lpage>.<pub-id pub-id-type="pmid">15838032</pub-id></mixed-citation></ref><ref id="cit0046"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hui</surname>
<given-names>FM</given-names></string-name>, <string-name><surname>Morrison</surname>
<given-names>DA</given-names></string-name></person-group>. <article-title>Genetic transformation in <italic>Streptococcus pneumoniae</italic>: nucleotide sequence analysis shows <italic>comA</italic>, a gene required for competence induction, to be a member of the bacterial ATP-dependent transport protein family</article-title>. <source>J Bacteriol</source>. <year>1991</year>;<volume>173</volume>(<issue>1</issue>):<fpage>372</fpage>&#x02013;<lpage>381</lpage>.<pub-id pub-id-type="pmid">1987129</pub-id></mixed-citation></ref><ref id="cit0047"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ishii</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Yano</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hayash</surname>
<given-names>H</given-names></string-name></person-group>. <article-title>Expression and characterization of the peptidase domain of <italic>Streptococcus pneumoniae</italic> ComA, a bifunctional ATP-binding cassette transporter involved in quorum sensing pathway</article-title>. <source>J Biol Chem</source>. <year>2006</year>;<volume>281</volume>(<issue>8</issue>):<fpage>4726</fpage>&#x02013;<lpage>4731</lpage>.<pub-id pub-id-type="pmid">16377622</pub-id></mixed-citation></ref><ref id="cit0048"><label>[48]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kwon</surname>
<given-names>H-Y</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>S-W</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>M-H</given-names></string-name>, et al</person-group>. <article-title>Effect of heat shock and mutations in ClpL and ClpP on virulence gene expression in <italic>Streptococcus pneumoniae</italic></article-title>. <source>Infect Immun</source>. <year>2003</year>;<volume>71</volume>(<issue>7</issue>):<fpage>3757</fpage>&#x02013;<lpage>3765</lpage>.<pub-id pub-id-type="pmid">12819057</pub-id></mixed-citation></ref><ref id="cit0049"><label>[49]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kwon</surname>
<given-names>H-Y</given-names></string-name>, <string-name><surname>Ogunniyi</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>M-H</given-names></string-name>, et al</person-group>. <article-title>The ClpP protease of <italic>Streptococcus pneumoniae</italic> modulates virulence gene expression and protects against fatal pneumococcal challenge</article-title>. <source>Infect Immun</source>. <year>2004</year>;<volume>72</volume>(10):<fpage>5646</fpage>&#x02013;<lpage>5653.</lpage><pub-id pub-id-type="pmid">15385462</pub-id></mixed-citation></ref><ref id="cit0050"><label>[50]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Immunization with a combination of three pneumococcal proteins confers additive and broad protection against <italic>Streptococcus pneumoniae</italic> infections in mice</article-title>. <source>Infect Immun</source>. <year>2010</year>;<volume>78</volume>(<issue>3</issue>):<fpage>1276</fpage>&#x02013;<lpage>1283</lpage>.<pub-id pub-id-type="pmid">20038538</pub-id></mixed-citation></ref><ref id="cit0051"><label>[51]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>
<given-names>J-O</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>J-Y</given-names></string-name>, <string-name><surname>Rhee D-K</surname>
<given-names>D-K</given-names></string-name></person-group>. <article-title><italic>Streptococcus pneumoniae</italic> ClpP protease induces apoptosis via caspase-independent pathway in human neuroblastoma cells: cytoplasmic relocalization of p53</article-title>. <source>Toxicon</source>. <year>2013</year>;<volume>70</volume>:<fpage>142</fpage>&#x02013;<lpage>152</lpage>.<pub-id pub-id-type="pmid">23643883</pub-id></mixed-citation></ref><ref id="cit0052"><label>[52]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ritchie</surname>
<given-names>ND</given-names></string-name>, <string-name><surname>Evans</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Dual</surname>
<given-names>RN</given-names></string-name></person-group><article-title>A-seq in <italic>Streptococcus pneumoniae</italic> infection reveals compartmentalized neutrophil responses in lung and pleural space</article-title>. <source>mSystems</source>. <year>2019</year>;<volume>4</volume>(<issue>4</issue>):<fpage>e00216</fpage>&#x02013;<lpage>19</lpage>.</mixed-citation></ref><ref id="cit0053"><label>[53]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Angel</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Ruzek</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hostetter</surname>
<given-names>MK</given-names></string-name></person-group>. <article-title>Degradation of C3 by <italic>Streptococcus pneumoniae</italic></article-title>. <source>J Infect Dis</source>. <year>1994</year>;<volume>170</volume>(<issue>3</issue>):<fpage>600</fpage>&#x02013;<lpage>608</lpage>.<pub-id pub-id-type="pmid">8077717</pub-id></mixed-citation></ref><ref id="cit0054"><label>[54]</label><mixed-citation publication-type="patent"><person-group person-group-type="author"><string-name><surname>Hostetter</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Dunny</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Nandiwada</surname>
<given-names>L</given-names></string-name></person-group>
<article-title>Human complement C3-degrading protein from <italic>Streptococcus pneumoniae</italic></article-title>. <source>United States patent number 6</source>,<comment>676</comment>,<fpage>943</fpage>; <date-in-citation>2004 <month>1</month><day>13</day></date-in-citation>.</mixed-citation></ref><ref id="cit0055"><label>[55]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Armstrong</surname>
<given-names>RN</given-names></string-name></person-group>. <article-title>Mechanistic diversity in a metalloenzyme superfamily</article-title>. <source>Biochemistry</source>. <year>2000</year>;<volume>39</volume>(<issue>45</issue>):<fpage>13625</fpage>&#x02013;<lpage>13632</lpage>.<pub-id pub-id-type="pmid">11076500</pub-id></mixed-citation></ref><ref id="cit0056"><label>[56]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carter</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Wolf</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Van Opijnen</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions</article-title>. <source>Cell Host Microbe</source>. <year>2014</year>;<volume>15</volume>(<issue>5</issue>):<fpage>587</fpage>&#x02013;<lpage>599</lpage>.<pub-id pub-id-type="pmid">24832453</pub-id></mixed-citation></ref><ref id="cit0057"><label>[57]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rowe</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Karlsson</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Echlin</surname>
<given-names>H</given-names></string-name>, et al</person-group>. <article-title>Bacterial factors required for transmission of <italic>Streptococcus pneumoniae</italic> in mammalian hosts</article-title>. <source>Cell Host Microbe</source>. <year>2019</year>;<volume>25</volume>(<issue>6</issue>):<fpage>884</fpage>&#x02013;<lpage>891</lpage>.<pub-id pub-id-type="pmid">31126758</pub-id></mixed-citation></ref><ref id="cit0058"><label>[58]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname>
<given-names>D</given-names></string-name>, <string-name><surname>San</surname>
<given-names>BH</given-names></string-name>, <string-name><surname>Moh</surname>
<given-names>SH</given-names></string-name>, et al</person-group>. <article-title>Structural basis for the substrate specificity of PepA from <italic>Streptococcus pneumoniae</italic>, a dodecameric tetrahedral protease</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2010</year>;<volume>391</volume>(<issue>1</issue>):<fpage>431</fpage>&#x02013;<lpage>436</lpage>.<pub-id pub-id-type="pmid">19914209</pub-id></mixed-citation></ref><ref id="cit0059"><label>[59]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lipinska</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Zylicz</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Georgopoulos</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>The HtrA (DegP) protein, essential for <italic>Escherichia coli</italic> survival at high temperatures, is an endopeptidase.</article-title>. <source>J Bacteriol</source>. <year>1990</year>;<volume>172</volume>(<issue>4</issue>):<fpage>1791</fpage>&#x02013;<lpage>1797</lpage>.<pub-id pub-id-type="pmid">2180903</pub-id></mixed-citation></ref><ref id="cit0060"><label>[60]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Stoppelaar</surname>
<given-names>SF</given-names></string-name>, <string-name><surname>Bootsma</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Zomer</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title><italic>Streptococcus pneumoniae</italic> serine protease HtrA, but not SFP or PrtA, is a major virulence factor in pneumonia</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>11</issue>):<fpage>e80062</fpage>.<pub-id pub-id-type="pmid">24244609</pub-id></mixed-citation></ref><ref id="cit0061"><label>[61]</label><mixed-citation publication-type="web"><article-title>European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI) InterPro</article-title>. <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/interpro/">https://www.ebi.ac.uk/interpro/</ext-link></mixed-citation></ref><ref id="cit0062"><label>[62]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Spiess</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Beil</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ehrmann</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein</article-title>. <source>Cell</source>. <year>1999</year>;<volume>97</volume>(<issue>3</issue>):<fpage>339</fpage>&#x02013;<lpage>347</lpage>.<pub-id pub-id-type="pmid">10319814</pub-id></mixed-citation></ref><ref id="cit0063"><label>[63]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peters</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Schweizer</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Beilharz</surname>
<given-names>K</given-names></string-name>, et al</person-group>. <article-title><italic>S</italic><italic>treptococcus pneumoniae</italic> PBP2x mid-cell localization requires the C-terminal PASTA domains and is essential for cell shape maintenance</article-title>. <source>Mol Microbiol</source>. <year>2014</year>;<volume>93</volume>(<issue>4</issue>):<fpage>733</fpage>&#x02013;<lpage>755</lpage>.</mixed-citation></ref><ref id="cit0064"><label>[64]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ibrahim</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Kerr</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>McCluskey</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Role of HtrA in the virulence and competence of <italic>Streptococcus pneumoniae</italic></article-title>. <source>Infect Immun</source>. <year>2004</year>;<volume>72</volume>(<issue>6</issue>):<fpage>3584</fpage>&#x02013;<lpage>3591</lpage>.<pub-id pub-id-type="pmid">15155668</pub-id></mixed-citation></ref><ref id="cit0065"><label>[65]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sebert</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>KP</given-names></string-name>, <string-name><surname>Plotnick</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Pneumococcal HtrA protease mediates inhibition of competence by the CiaRH two-component signaling system</article-title>. <source>J Bacteriol</source>. <year>2005</year>;<volume>187</volume>(<issue>12</issue>):<fpage>3969</fpage>&#x02013;<lpage>3979</lpage>.<pub-id pub-id-type="pmid">15937159</pub-id></mixed-citation></ref><ref id="cit0066"><label>[66]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cassone</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gagne</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Spruce</surname>
<given-names>LA</given-names></string-name>, et al</person-group>. <article-title>The HtrA protease from <italic>Streptococcus pneumoniae</italic> digests both denatured proteins and the competence-stimulating peptide</article-title>. <source>J Biol Chem</source>. <year>2012</year>;<volume>287</volume>(<issue>46</issue>):<fpage>38449</fpage>&#x02013;<lpage>38459</lpage>.<pub-id pub-id-type="pmid">23012372</pub-id></mixed-citation></ref><ref id="cit0067"><label>[67]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>Y</given-names></string-name>, et al</person-group>. <article-title>HtrA-mediated selective degradation of DNA uptake apparatus accelerates termination of pneumococcal transformation</article-title>. <source>Mol Microbiol</source>. <year>2019</year>;<volume>112</volume>(<issue>4</issue>):<fpage>1308</fpage>&#x02013;<lpage>1325</lpage>.<pub-id pub-id-type="pmid">31396996</pub-id></mixed-citation></ref><ref id="cit0068"><label>[68]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schnorpfeil</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kranz</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kov&#x000e1;cs</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Target evaluation of the non-coding csRNAs reveals a link of the two-component regulatory system CiaRH to competence control in <italic>Streptococcus pneumonia</italic> R6</article-title>. <source>Mol Microbiol</source>. <year>2013</year>;<volume>89</volume>(<issue>2</issue>):<fpage>334</fpage>&#x02013;<lpage>349</lpage>.<pub-id pub-id-type="pmid">23710838</pub-id></mixed-citation></ref><ref id="cit0069"><label>[69]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stevens</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Zwack</surname>
<given-names>EE</given-names></string-name>, et al</person-group>. <article-title>Competence in <italic>Streptococcus pneumoniae</italic> is regulated by the rate of ribosomal decoding errors</article-title>. <source>mBio</source>. <year>2011</year>;<volume>2</volume>(<issue>5</issue>):<fpage>e00071</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">21933920</pub-id></mixed-citation></ref><ref id="cit0070"><label>[70]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dawid</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sebert</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Weiser</surname>
<given-names>JN</given-names></string-name></person-group>. <article-title>Bacteriocin activity of <italic>Streptococcus pneumoniae</italic> is controlled by the serine protease HtrA via posttranscriptional regulation</article-title>. <source>J Bacteriol</source>. <year>2009</year>;<volume>191</volume>(<issue>5</issue>):<fpage>1509</fpage>&#x02013;<lpage>1518</lpage>.<pub-id pub-id-type="pmid">19103930</pub-id></mixed-citation></ref><ref id="cit0071"><label>[71]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kochan</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Dawid</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>The HtrA protease of <italic>Streptococcus pneumoniae</italic> controls density-dependent stimulation of the bacteriocin <italic>blp</italic> locus via disruption of pheromone secretion</article-title>. <source>J Bacteriol</source>. <year>2013</year>;<volume>195</volume>(<issue>7</issue>):<fpage>1561</fpage>&#x02013;<lpage>1572</lpage>.<pub-id pub-id-type="pmid">23354751</pub-id></mixed-citation></ref><ref id="cit0072"><label>[72]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sebert</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Palmer</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Rosenberg</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Microarray-based identification of <italic>htrA</italic>, a <italic>Streptococcus pneumoniae</italic> gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization</article-title>. <source>Infect Immun</source>. <year>2002</year>;<volume>70</volume>(<issue>8</issue>):<fpage>4059</fpage>&#x02013;<lpage>4067</lpage>.<pub-id pub-id-type="pmid">12117912</pub-id></mixed-citation></ref><ref id="cit0073"><label>[73]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wikstr&#x000f6;m</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Dahl&#x000e9;n</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Kaijser</surname>
<given-names>B</given-names></string-name>, et al</person-group>. <article-title>Degradation of human immunoglobulins by proteases from <italic>Streptococcus pneumoniae</italic> obtained from various human sources.</article-title>. <source>Infect Immun</source>. <year>1984</year>;<volume>44</volume>(<issue>1</issue>):<fpage>33</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">6368393</pub-id></mixed-citation></ref><ref id="cit0074"><label>[74]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reinholdt</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kilian</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Comparative analysis of immunoglobulin A1 protease activity among bacteria representing different genera, species, and strains</article-title>. <source>Infect Immun</source>. <year>1997</year>;<volume>65</volume>(<issue>11</issue>):<fpage>4452</fpage>&#x02013;<lpage>4459</lpage>.<pub-id pub-id-type="pmid">9353019</pub-id></mixed-citation></ref><ref id="cit0075"><label>[75]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wani</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Gilbert</surname>
<given-names>JV</given-names></string-name>, <string-name><surname>Plaut</surname>
<given-names>AG</given-names></string-name>, et al</person-group>. <article-title>Identification, cloning, and sequencing of the immunoglobulin A1 protease gene of <italic>Streptococcus pneumoniae</italic>.</article-title>. <source>Infect Immun</source>. <year>1996</year>;<volume>64</volume>(<issue>10</issue>):<fpage>3967</fpage>&#x02013;<lpage>3974</lpage>.<pub-id pub-id-type="pmid">8926056</pub-id></mixed-citation></ref><ref id="cit0076"><label>[76]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Poulsen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Reinholdt</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jespersgaard</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>A comprehensive genetic study of streptococcal immunoglobulin A1 proteases: evidence for recombination within and between species</article-title>. <source>Infect Immun</source>. <year>1998</year>;<volume>66</volume>(<issue>1</issue>):<fpage>181</fpage>&#x02013;<lpage>190</lpage>.<pub-id pub-id-type="pmid">9423856</pub-id></mixed-citation></ref><ref id="cit0077"><label>[77]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Poulsen</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Reinholdt</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kilian</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Characterization of the <italic>Streptococcus pneumoniae</italic> immunoglobulin A1 protease (<italic>iga</italic>) and its translation product</article-title>. <source>Infect Immun</source>. <year>1996</year>;<volume>64</volume>(<issue>10</issue>):<fpage>3957</fpage>&#x02013;<lpage>3966</lpage>.<pub-id pub-id-type="pmid">8926055</pub-id></mixed-citation></ref><ref id="cit0078"><label>[78]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chi</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Rahkola</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Kendrick</surname>
<given-names>AA</given-names></string-name>, et al</person-group>. <article-title><italic>Streptococcus pneumoniae</italic> IgA1 protease: a metalloprotease that can catalyze in a split manner in vitro</article-title>. <source>Protein Sci</source>. <year>2017</year>;<volume>26</volume>(<issue>3</issue>):<fpage>600</fpage>&#x02013;<lpage>610</lpage>.<pub-id pub-id-type="pmid">28028839</pub-id></mixed-citation></ref><ref id="cit0079"><label>[79]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kilian</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mestecky</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kulhavy</surname>
<given-names>R</given-names></string-name>, et al</person-group>. <article-title>IgA1 proteases from <italic>Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis</italic>, and <italic>Streptococcus sanguis</italic>: comparative immunochemical studies</article-title>. <source>J Immunol</source>. <year>1980</year>;<volume>124</volume>(<issue>6</issue>):<fpage>2596</fpage>&#x02013;<lpage>2600</lpage>.<pub-id pub-id-type="pmid">6768797</pub-id></mixed-citation></ref><ref id="cit0080"><label>[80]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Batten</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Senior</surname>
<given-names>BW</given-names></string-name>, <string-name><surname>Kilian</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Amino acid sequence requirements in the hinge of human immunoglobulin A1 (IgA1) for cleavage by streptococcal IgA1 proteases</article-title>. <source>Infect Immun</source>. <year>2003</year>;<volume>72</volume>(<issue>3</issue>):<fpage>1462</fpage>&#x02013;<lpage>1469</lpage>.</mixed-citation></ref><ref id="cit0081"><label>[81]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Senior</surname>
<given-names>BW</given-names></string-name>, <string-name><surname>Batten</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Kilian</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Amino acid sequence requirements in the human IgA1 hinge for cleavage by streptococcal IgA1 proteases</article-title>. <source>Biochem Soc Trans</source>. <year>2002</year>;<volume>30</volume>(<issue>3</issue>):<fpage>A92</fpage>.</mixed-citation></ref><ref id="cit0082"><label>[82]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Janoff</surname>
<given-names>EN</given-names></string-name>, <string-name><surname>Rubins</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Fasching</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>Pneumococcal IgA1 protease subverts specific protection by human IgA1</article-title>. <source>Mucosal Immunol</source>. <year>2014</year>;<volume>7</volume>(<issue>2</issue>):<fpage>249</fpage>&#x02013;<lpage>256</lpage>.<pub-id pub-id-type="pmid">23820749</pub-id></mixed-citation></ref><ref id="cit0083"><label>[83]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weiser</surname>
<given-names>JN</given-names></string-name>, <string-name><surname>Bae</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Fasching</surname>
<given-names>C</given-names></string-name>, et al</person-group>. <article-title>Antibody-enhanced pneumococcal adherence requires IgA1 protease</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2003</year>;<volume>100</volume>(<issue>7</issue>):<fpage>4215</fpage>&#x02013;<lpage>4220</lpage>.<pub-id pub-id-type="pmid">12642661</pub-id></mixed-citation></ref><ref id="cit0084"><label>[84]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chiavolini</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Memmi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Maggi</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>The three extra-cellular zinc metalloproteinases of <italic>Streptococcus pneumoniae</italic> have a different impact on virulence in mice</article-title>. <source>BMC Microbiol</source>. <year>2003</year>;<volume>3</volume>(<issue>1</issue>):<fpage>14</fpage>.<pub-id pub-id-type="pmid">12841855</pub-id></mixed-citation></ref><ref id="cit0085"><label>[85]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Audouy</surname>
<given-names>SAL</given-names></string-name>, <string-name><surname>Van Selm</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Van Roosmalen</surname>
<given-names>ML</given-names></string-name>, et al</person-group>. <article-title>Development of lactococcal GEM-based pneumococcal vaccines</article-title>. <source>Vaccine</source>. <year>2007</year>;<volume>25</volume>(<issue>13</issue>):<fpage>2497</fpage>&#x02013;<lpage>2506</lpage>.<pub-id pub-id-type="pmid">17081660</pub-id></mixed-citation></ref><ref id="cit0086"><label>[86]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abdullah</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Guti&#x000e9;rrez-Fern&#x000e1;ndez</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pribyl</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Structure of the pneumococcal l-d-carboxypeptidase DacB and the pathophysiological effects of disabled cell wall hydrolases DacA and DacB</article-title>. <source>Mol Microbiol</source>. <year>2014</year>;<volume>93</volume>(<issue>6</issue>):<fpage>1183</fpage>&#x02013;<lpage>1206</lpage>.<pub-id pub-id-type="pmid">25060741</pub-id></mixed-citation></ref><ref id="cit0087"><label>[87]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Morlot</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Pernot</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Le Gouellec</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title>Crystal structure of apeptidoglycan synthesis regulatory factor (PBP3) from <italic>Streptococcus pneumoniae</italic></article-title>. <source>J Biol Chem</source>. <year>2005</year>;<volume>280</volume>(<issue>16</issue>):<fpage>15984</fpage>&#x02013;<lpage>15991</lpage>.<pub-id pub-id-type="pmid">15596446</pub-id></mixed-citation></ref><ref id="cit0088"><label>[88]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Severin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Schuster</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Hakenbeck</surname>
<given-names>R</given-names></string-name>, et al</person-group>. <article-title>Altered murein composition in a DD-carboxypeptidase mutant of <italic>Streptococcus pneumoniae</italic>.</article-title>. <source>J Bacteriol</source>. <year>1992</year>;<volume>174</volume>(<issue>15</issue>):<fpage>5152</fpage>&#x02013;<lpage>5155</lpage>.<pub-id pub-id-type="pmid">1629174</pub-id></mixed-citation></ref><ref id="cit0089"><label>[89]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barendt</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Sham</surname>
<given-names>L-T</given-names></string-name>, <string-name><surname>Winkler</surname>
<given-names>ME</given-names></string-name></person-group>. <article-title>Characterization of mutants deficient in the L,D-carboxypeptidase (DacB) and WalRK (VicRK) regulon, involved in peptidoglycan maturation of <italic>Streptococcus pneumoniae</italic> serotype 2 strain D39</article-title>. <source>J Bacteriol</source>. <year>2011</year>;<volume>193</volume>(<issue>9</issue>):<fpage>2290</fpage>&#x02013;<lpage>2300</lpage>.<pub-id pub-id-type="pmid">21378199</pub-id></mixed-citation></ref><ref id="cit0090"><label>[90]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoyland</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Aldridge</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Cleverley</surname>
<given-names>RM</given-names></string-name>, et al</person-group>. <article-title>Structure of the LdcB LD-carboxypeptidase reveals the molecular basis of peptidoglycan recognition</article-title>. <source>Structure</source>. <year>2014</year>;<volume>22</volume>(<issue>7</issue>):<fpage>949</fpage>&#x02013;<lpage>960</lpage>.<pub-id pub-id-type="pmid">24909784</pub-id></mixed-citation></ref><ref id="cit0091"><label>[91]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>YL</given-names></string-name>, et al</person-group>. <article-title>Structural and biochemical analyses of the <italic>Streptococcus pneumoniae</italic> L,D-carboxypeptidase DacB</article-title>. <source>Acta Crystallogr D Biol Crystallogr</source>. <year>2015</year>;<volume>71</volume>(<issue>Pt 2</issue>):<fpage>283</fpage>&#x02013;<lpage>292</lpage>.<pub-id pub-id-type="pmid">25664738</pub-id></mixed-citation></ref><ref id="cit0092"><label>[92]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Agarwal</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Kuchipudi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fulde</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title><italic>Streptococcus pneumoniae</italic> endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells</article-title>. <source>J Biol Chem</source>. <year>2013</year>;<volume>288</volume>(<issue>10</issue>):<fpage>6849</fpage>&#x02013;<lpage>6863</lpage>.<pub-id pub-id-type="pmid">23341464</pub-id></mixed-citation></ref><ref id="cit0093"><label>[93]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Agarwal</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Sroka</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fulde</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Binding of <italic>Streptococcus pneumoniae</italic> endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence</article-title>. <source>J Biol Chem</source>. <year>2014</year>;<volume>289</volume>(<issue>22</issue>):<fpage>15833</fpage>&#x02013;<lpage>15844</lpage>.<pub-id pub-id-type="pmid">24739385</pub-id></mixed-citation></ref><ref id="cit0094"><label>[94]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bergmann</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rohde</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Preer</surname>
<given-names>KT</given-names></string-name>, et al</person-group>. <article-title>The nine residue plasminogen-binding motif of the pneumococcal enolase is the major cofactor of plasmin-mediated degradation of extracellular matrix, dissolution of fibrin and transmigration</article-title>. <source>Thromb Haemost</source>. <year>2005</year>;<volume>94</volume>(<issue>2</issue>):<fpage>304</fpage>&#x02013;<lpage>311</lpage>.<pub-id pub-id-type="pmid">16113819</pub-id></mixed-citation></ref><ref id="cit0095"><label>[95]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Yuan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, et al</person-group>. <article-title><italic>Streptococcus pneumonia</italic> PepO promotes host anti-infection defense via autophagy in a Toll-like receptor 2/4 dependent manner</article-title>. <source>Virulence</source>. <year>2020</year>;<volume>11</volume>(<issue>1</issue>):<fpage>270</fpage>&#x02013;<lpage>282</lpage>.<pub-id pub-id-type="pmid">32172666</pub-id></mixed-citation></ref><ref id="cit0096"><label>[96]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yao</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Lan</surname>
<given-names>K</given-names></string-name>, et al</person-group>. <article-title><italic>Streptococcus pneumoniae</italic> endopeptidase O (PepO) enhances particle uptake by macrophages in a Toll-like receptor 2- and miR-155-dependent manner</article-title>. <source>Infect Immun</source>. <year>2017</year>;<volume>85</volume>(<issue>4</issue>):<fpage>e01012</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">28193634</pub-id></mixed-citation></ref><ref id="cit0097"><label>[97]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Yao</surname>
<given-names>H</given-names></string-name>, et al</person-group>. <article-title><italic>Streptococcus pneumoniae</italic> endopeptidase O (PepO) elicits a strong innate immune response in mice via TLR2 and TLR4 signaling pathways</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2016</year>;<volume>6</volume>:<fpage>23</fpage>.<pub-id pub-id-type="pmid">26973817</pub-id></mixed-citation></ref><ref id="cit0098"><label>[98]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hostetter</surname>
<given-names>MK</given-names></string-name></person-group>. <article-title>Opsonic and nonopsonic interactions of C3 with <italic>Streptococcus pneumoniae</italic></article-title>. <source>Microb Drug Resist</source>. <year>1999</year>;<volume>5</volume>(<issue>2</issue>):<fpage>85</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">10432269</pub-id></mixed-citation></ref><ref id="cit0099"><label>[99]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Masi</surname>
<given-names>AW</given-names></string-name>, <string-name><surname>Barniak</surname>
<given-names>V</given-names></string-name>, et al</person-group>. <article-title>Recombinant PhpA protein, a unique histidine motif-containing protein from <italic>Streptococcus pneumoniae</italic>, protects mice against intranasal pneumococcal challenge</article-title>. <source>Infect Immun</source>. <year>2001</year>;<volume>69</volume>(<issue>6</issue>):<fpage>3827</fpage>&#x02013;<lpage>3836</lpage>.<pub-id pub-id-type="pmid">11349048</pub-id></mixed-citation></ref><ref id="cit0100"><label>[100]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adamou</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Heinrichs</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Erwin</surname>
<given-names>AL</given-names></string-name>, et al</person-group>. <article-title>Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis</article-title>. <source>Infect Immun</source>. <year>2001</year>;<volume>69</volume>(<issue>2</issue>):<fpage>949</fpage>&#x02013;<lpage>958</lpage>.<pub-id pub-id-type="pmid">11159990</pub-id></mixed-citation></ref><ref id="cit0101"><label>[101]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Melin</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Di Paolo</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Tikkanen</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>Interaction of pneumococcal histidine triad proteins with human complement</article-title>. <source>Infect Immun</source>. <year>2010</year>;<volume>78</volume>(<issue>5</issue>):<fpage>2089</fpage>&#x02013;<lpage>2098</lpage>.<pub-id pub-id-type="pmid">20194599</pub-id></mixed-citation></ref><ref id="cit0102"><label>[102]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ogunniyi</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Grabowicz</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mahdi</surname>
<given-names>LK</given-names></string-name>, et al</person-group>. <article-title>Pneumococcal histidine triad proteins are regulated by the Zn <sup>2+</sup>++ -dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H</article-title>. <source>Faseb J</source>. <year>2009</year>;<volume>23</volume>(<issue>3</issue>):<fpage>731</fpage>&#x02013;<lpage>738</lpage>.<pub-id pub-id-type="pmid">18971260</pub-id></mixed-citation></ref><ref id="cit0103"><label>[103]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bethe</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Nau</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Wellmer</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title>The cell wall-associated serine protease PrtA: a highly conserved virulence factor of <italic>Streptococcus pneumoniae</italic></article-title>. <source>FEMS Microbiol Lett</source>. <year>2001</year>;<volume>205</volume>(<issue>1</issue>):<fpage>99</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="pmid">11728722</pub-id></mixed-citation></ref><ref id="cit0104"><label>[104]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mahdi</surname>
<given-names>LK</given-names></string-name>, <string-name><surname>Van Der Hoek</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Ebrahimie</surname>
<given-names>E</given-names></string-name>, et al</person-group>. <article-title>Characterization of pneumococcal genes involved in bloodstream invasion in a mouse model</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>11</issue>):<fpage>e0141816</fpage>.<pub-id pub-id-type="pmid">26539717</pub-id></mixed-citation></ref><ref id="cit0105"><label>[105]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Frolet</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Beniazza</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Roux</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>New adhesin functions of surface-exposed pneumococcal proteins</article-title>. <source>BMC Microbiol</source>. <year>2010</year>;<volume>10</volume>(<issue>1</issue>):<fpage>190</fpage>.<pub-id pub-id-type="pmid">20624274</pub-id></mixed-citation></ref><ref id="cit0106"><label>[106]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mirza</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wilson</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Benjamin</surname>
<given-names>WH</given-names></string-name>, et al</person-group>. <article-title>Serine protease PrtA from <italic>Streptococcus pneumoniae</italic> plays a role in the killing of <italic>S</italic>. pneumoniae by apolactoferrin</article-title>. <source>Infect Immun</source>. <year>2011</year>;<volume>79</volume>(<issue>6</issue>):<fpage>2440</fpage>&#x02013;<lpage>2450</lpage>.<pub-id pub-id-type="pmid">21422179</pub-id></mixed-citation></ref><ref id="cit0107"><label>[107]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>YB</given-names></string-name>, <string-name><surname>Greenberg</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Lacks</surname>
<given-names>SA</given-names></string-name></person-group>. <article-title>Analysis of a <italic>Streptococcus pneumoniae</italic> gene encoding signal peptidase I and overproduction of the enzyme</article-title>. <source>Gene</source>. <year>1997</year>;<volume>194</volume>(<issue>2</issue>):<fpage>249</fpage>&#x02013;<lpage>255</lpage>.<pub-id pub-id-type="pmid">9272867</pub-id></mixed-citation></ref><ref id="cit0108"><label>[108]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khandavilli</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Homer</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Yuste</surname>
<given-names>J</given-names></string-name>, et al</person-group>. <article-title>Maturation of <italic>Streptococcus pneumoniae</italic> lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulence</article-title>. <source>Mol Microbiol</source>. <year>2008</year>;<volume>67</volume>(<issue>3</issue>):<fpage>541</fpage>&#x02013;<lpage>557</lpage>.<pub-id pub-id-type="pmid">18086214</pub-id></mixed-citation></ref><ref id="cit0109"><label>[109]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pribyl</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Moche</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Dreisbach</surname>
<given-names>A</given-names></string-name>, et al</person-group>. <article-title>Influence of impaired lipoprotein biogenesis on surface and exoproteome of <italic>Streptococcus pneumoniae</italic></article-title>. <source>J Proteome Res</source>. <year>2014</year>;<volume>13</volume>(<issue>2</issue>):<fpage>650</fpage>&#x02013;<lpage>667</lpage>.<pub-id pub-id-type="pmid">24387739</pub-id></mixed-citation></ref><ref id="cit0110"><label>[110]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Camilli</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Pettini</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Del Grosso</surname>
<given-names>M</given-names></string-name>, et al</person-group>. <article-title>Zinc metalloproteinase genes in clinical isolates of <italic>Streptococcus pneumoniae</italic>: association of the full array with a clonal cluster comprising serotypes 8 and 11A</article-title>. <source>Microbiology</source>. <year>2006</year>;<volume>152</volume>(<issue>Pt 2</issue>):<fpage>313</fpage>&#x02013;<lpage>321</lpage>.<pub-id pub-id-type="pmid">16436419</pub-id></mixed-citation></ref><ref id="cit0111"><label>[111]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Novak</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Charpentier</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Braun</surname>
<given-names>JS</given-names></string-name>, et al</person-group>. <article-title>Extracellular targeting of choline-binding proteins in <italic>Streptococcus pneumoniae</italic> by a zinc metalloprotease</article-title>. <source>Mol Microbiol</source>. <year>2000</year>;<volume>36</volume>(<issue>2</issue>):<fpage>366</fpage>&#x02013;<lpage>376</lpage>.<pub-id pub-id-type="pmid">10792723</pub-id></mixed-citation></ref><ref id="cit0112"><label>[112]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Cui</surname>
<given-names>Y</given-names></string-name>, et al</person-group>. <article-title>Immunization with a ZmpB-based protein vaccine could protect against pneumococcal diseases in mice</article-title>. <source>Infect Immun</source>. <year>2011</year>;<volume>79</volume>(<issue>2</issue>):<fpage>867</fpage>&#x02013;<lpage>878</lpage>.<pub-id pub-id-type="pmid">21098102</pub-id></mixed-citation></ref><ref id="cit0113"><label>[113]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blue</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Paterson</surname>
<given-names>GK</given-names></string-name>, <string-name><surname>Kerr</surname>
<given-names>AR</given-names></string-name>, et al</person-group>. <article-title>ZmpB, a novel virulence factor of <italic>Streptococcus pneumoniae</italic> that induces tumor necrosis factor alpha production in the respiratory tract</article-title>. <source>Infect Immun</source>. <year>2003</year>;<volume>71</volume>(<issue>9</issue>):<fpage>4925</fpage>&#x02013;<lpage>4935</lpage>.<pub-id pub-id-type="pmid">12933834</pub-id></mixed-citation></ref><ref id="cit0114"><label>[114]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hsieh</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Tsao</surname>
<given-names>PN</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>CL</given-names></string-name>, et al</person-group>. <article-title>Establishment of a young mouse model and identification of an allelic variation of zmpB in complicated pneumonia caused by <italic>Streptococcus pneumoniae</italic></article-title>. <source>Crit Care Med</source>. <year>2008</year>;<volume>36</volume>(<issue>4</issue>):<fpage>1248</fpage>&#x02013;<lpage>1255</lpage>.<pub-id pub-id-type="pmid">18379252</pub-id></mixed-citation></ref><ref id="cit0115"><label>[115]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cremers</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Kokmeijer</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Groh</surname>
<given-names>L</given-names></string-name>, et al</person-group>. <article-title>The role of ZmpC in the clinical manifestation of invasive pneumococcal disease</article-title>. <source>Int J Med Microbiol</source>. <year>2014</year>;<volume>304</volume>(<issue>8</issue>):<fpage>984</fpage>&#x02013;<lpage>989</lpage>.<pub-id pub-id-type="pmid">25023076</pub-id></mixed-citation></ref><ref id="cit0116"><label>[116]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Surewaard</surname>
<given-names>BG</given-names></string-name>, <string-name><surname>Trzci&#x00144;ski</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Jacobino</surname>
<given-names>SR</given-names></string-name>, et al</person-group>. <article-title>Pneumococcal immune evasion: zmpC inhibits neutrophil influx</article-title>. <source>Cell Microbiol</source>. <year>2013</year>;<volume>15</volume>(<issue>10</issue>):<fpage>1753</fpage>&#x02013;<lpage>1765</lpage>.<pub-id pub-id-type="pmid">23601501</pub-id></mixed-citation></ref><ref id="cit0117"><label>[117]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Oggioni</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Memmi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Maggi</surname>
<given-names>T</given-names></string-name>, et al</person-group>. <article-title>Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia</article-title>. <source>Mol Microbiol</source>. <year>2003</year>;<volume>49</volume>(<issue>3</issue>):<fpage>795</fpage>&#x02013;<lpage>805</lpage>.<pub-id pub-id-type="pmid">12864860</pub-id></mixed-citation></ref><ref id="cit0118"><label>[118]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yamaguchi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nakata</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sumioka</surname>
<given-names>R</given-names></string-name>, et al</person-group>. <article-title>Zinc metalloproteinase ZmpC suppresses experimental pneumococcal meningitis by inhibiting bacterial invasion of central nervous system</article-title>. <source>Virulence</source>. <year>2017</year>;<volume>8</volume>(<issue>8</issue>):<fpage>1516</fpage>&#x02013;<lpage>1524</lpage>.<pub-id pub-id-type="pmid">28489958</pub-id></mixed-citation></ref><ref id="cit0119"><label>[119]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Hayashida</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bennett</surname>
<given-names>AE</given-names></string-name>, et al</person-group>. <article-title><italic>Streptococcus pneumoniae</italic> sheds syndecan-1 ectodomains through ZmpC, a metalloproteinase virulence factor</article-title>. <source>J Biol Chem</source>. <year>2007</year>;<volume>282</volume>(<issue>1</issue>):<fpage>159</fpage>&#x02013;<lpage>167</lpage>.<pub-id pub-id-type="pmid">17098735</pub-id></mixed-citation></ref><ref id="cit0120"><label>[120]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Govindarajan</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Menon</surname>
<given-names>BB</given-names></string-name>, <string-name><surname>Spurr-Michaud</surname>
<given-names>S</given-names></string-name>, et al</person-group>. <article-title>A metalloproteinase secreted by <italic>Streptococcus pneumoniae</italic> removes membrane mucin MUC16 from the epithelial glycocalyx barrier</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>3</issue>):<fpage>e32418</fpage>.<pub-id pub-id-type="pmid">22412870</pub-id></mixed-citation></ref><ref id="cit0121"><label>[121]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andre</surname>
<given-names>GO</given-names></string-name>, <string-name><surname>Converso</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Politano</surname>
<given-names>WR</given-names></string-name>, et al</person-group>. <article-title>Role of <italic>Streptococcus pneumoniae</italic> proteins in evasion of complement-mediated immunity</article-title>. <source>Front Microbiol</source>. <year>2017</year>;<volume>8</volume>:<fpage>224</fpage>.<pub-id pub-id-type="pmid">28265264</pub-id></mixed-citation></ref><ref id="cit0122"><label>[122]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lanie</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Ng</surname>
<given-names>WL</given-names></string-name>, <string-name><surname>Kazmierczak</surname>
<given-names>KM</given-names></string-name>, et al</person-group>. <article-title>Genome sequence of Avery&#x02019;s virulent serotype 2 strain D39 of <italic>Streptococcus pneumoniae</italic> and comparison with that of unencapsulated laboratory strain R6</article-title>. <source>J Bacteriol</source>. <year>2007</year>;<volume>189</volume>(<issue>1</issue>):<fpage>38</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">17041037</pub-id></mixed-citation></ref><ref id="cit0123"><label>[123]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tettelin</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Nelson</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Paulsen</surname>
<given-names>IT</given-names></string-name>, et al</person-group>. <article-title>Complete genome sequence of a virulent isolate of <italic>Streptococcus pneumoniae</italic></article-title>. <source>Science</source>. <year>2001</year>;<volume>293</volume>(<issue>5529</issue>):<fpage>498</fpage>&#x02013;<lpage>506</lpage>.<pub-id pub-id-type="pmid">11463916</pub-id></mixed-citation></ref><ref id="cit0124"><label>[124]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Slager</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Aprianto</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Veening</surname>
<given-names>J-W</given-names></string-name></person-group>. <article-title>Deep genome annotation of the opportunistic human pathogen <italic>Streptococcus pneumoniae</italic> D39</article-title>. <source>Nucleic Acids Res</source>. <year>2018</year>;<volume>46</volume>(<issue>19</issue>):<fpage>9971</fpage>&#x02013;<lpage>9989</lpage>.<pub-id pub-id-type="pmid">30107613</pub-id></mixed-citation></ref></ref-list></back></article>